Token ID	Token	Lemma	POS
es001.s001.t001	En		X
es001.s001.t002	el		X
es001.s001.t003	presente	presente	J
es001.s001.t004	documento	documento	N
es001.s001.t005	se		X
es001.s001.t006	resume	resumir	V
es001.s001.t007	el		X
es001.s001.t008	Informe	informe	N
es001.s001.t009	Público	público	J
es001.s001.t010	Europeo	europeo	J
es001.s001.t011	de		X
es001.s001.t012	Evaluación	evaluación	N
es001.s001.t013	(		X
es001.s001.t014	EPAR	epar	N
es001.s001.t015	)		X
es001.s001.t016	.		X
es001.s002.t001	En		X
es001.s002.t002	él		X
es001.s002.t003	se		X
es001.s002.t004	explica	explicar	V
es001.s002.t005	cómo	cómo	R
es001.s002.t006	el		X
es001.s002.t007	Comité	comité	N
es001.s002.t008	de		X
es001.s002.t009	Medicamentos	medicamento	N
es001.s002.t010	de		X
es001.s002.t011	Uso	uso	N
es001.s002.t012	Humano	humano	J
es001.s002.t013	(		X
es001.s002.t014	CHMP	chmp	N
es001.s002.t015	)		X
es001.s002.t016	ha	haber	V
es001.s002.t017	evaluado	evaluar	V
es001.s002.t018	los		X
es001.s002.t019	estudios	estudio	N
es001.s002.t020	realizados	realizar	V
es001.s002.t021	con		X
es001.s002.t022	el		X
es001.s002.t023	medicamento	medicamento	N
es001.s002.t024	a fin de		X
es001.s002.t025	emitir	emitir	V
es001.s002.t026	unas		X
es001.s002.t027	recomendaciones	recomendación	N
es001.s002.t028	sobre		X
es001.s002.t029	su		X
es001.s002.t030	uso	uso	N
es001.s002.t031	.		X
es001.s003.t001	Si		X
es001.s003.t002	desea	desear	V
es001.s003.t003	más	más	R
es001.s003.t004	información	información	N
es001.s003.t005	sobre		X
es001.s003.t006	su		X
es001.s003.t007	enfermedad	enfermedad	N
es001.s003.t008	o		X
es001.s003.t009	el		X
es001.s003.t010	tratamiento	tratamiento	N
es001.s003.t011	de		X
es001.s003.t012	la		X
es001.s003.t013	misma	mismo	J
es001.s003.t014	,		X
es001.s003.t015	le		X
es001.s003.t016	aconsejamos	aconsejar	V
es001.s003.t017	que		X
es001.s003.t018	lea	leer	V
es001.s003.t019	el		X
es001.s003.t020	prospecto	prospecto	N
es001.s003.t021	(		X
es001.s003.t022	incluido	incluir	V
es001.s003.t023	en		X
es001.s003.t024	el		X
es001.s003.t025	EPAR	epar	N
es001.s003.t026	)		X
es001.s003.t027	o		X
es001.s003.t028	pregunte	preguntar	V
es001.s003.t029	a		X
es001.s003.t030	su		X
es001.s003.t031	médico	médico	N
es001.s003.t032	o		X
es001.s003.t033	su		X
es001.s003.t034	farmacéutico	farmacéutico	N
es001.s003.t035	.		X
es001.s004.t001	Si		X
es001.s004.t002	desea	desear	V
es001.s004.t003	más	más	R
es001.s004.t004	información	información	N
es001.s004.t005	sobre		X
es001.s004.t006	el		X
es001.s004.t007	fundamento	fundamento	N
es001.s004.t008	en		X
es001.s004.t009	el		X
es001.s004.t010	que		X
es001.s004.t011	se		X
es001.s004.t012	han	haber	V
es001.s004.t013	basado	basar	V
es001.s004.t014	las		X
es001.s004.t015	recomendaciones	recomendación	N
es001.s004.t016	del		X
es001.s004.t017	CHMP	chmp	N
es001.s004.t018	,		X
es001.s004.t019	le		X
es001.s004.t020	aconsejamos	aconsejar	V
es001.s004.t021	que		X
es001.s004.t022	lea	leer	V
es001.s004.t023	el		X
es001.s004.t024	Debate	debate	N
es001.s004.t025	Científico	científico	J
es001.s004.t026	(		X
es001.s004.t027	también	también	R
es001.s004.t028	incluido	incluir	V
es001.s004.t029	en		X
es001.s004.t030	el		X
es001.s004.t031	EPAR	epar	N
es001.s004.t032	)		X
es001.s004.t033	.		X
es001.s005.t001	¿Qué		X
es001.s005.t002	es	ser	V
es001.s005.t003	Alimta	alimta	N
es001.s005.t004	?		X
es001.s006.t001	Alimta	alimta	N
es001.s006.t002	es	ser	V
es001.s006.t003	un		X
es001.s006.t004	polvo	polvo	N
es001.s006.t005	con		X
es001.s006.t006	el		X
es001.s006.t007	que		X
es001.s006.t008	se		X
es001.s006.t009	prepara	preparar	V
es001.s006.t010	una		X
es001.s006.t011	solución	solución	N
es001.s006.t012	para		X
es001.s006.t013	perfusión	perfusión	N
es001.s006.t014	(		X
es001.s006.t015	goteo	goteo	N
es001.s006.t016	en		X
es001.s006.t017	vena	vena	N
es001.s006.t018	)		X
es001.s006.t019	.		X
es001.s007.t001	Contiene	contener	V
es001.s007.t002	el		X
es001.s007.t003	principio	principio	N
es001.s007.t004	activo	activo	J
es001.s007.t005	pemetrexed	pemetrexed	N
es001.s007.t006	.		X
es001.s008.t001	¿Para		X
es001.s008.t002	qué		X
es001.s008.t003	se		X
es001.s008.t004	utiliza	utilizar	V
es001.s008.t005	Alimta	alimta	N
es001.s008.t006	?		X
es001.s009.t001	Alimta	alimta	N
es001.s009.t002	está	estar	V
es001.s009.t003	indicado	indicar	V
es001.s009.t004	para		X
es001.s009.t005	el		X
es001.s009.t006	tratamiento	tratamiento	N
es001.s009.t007	de		X
es001.s009.t008	dos		X
es001.s009.t009	tipos	tipo	N
es001.s009.t010	de		X
es001.s009.t011	cáncer	cáncer	N
es001.s009.t012	:		X
es001.s009.t013	mesotelioma	mesotelioma	N
es001.s009.t014	pleural	pleural	J
es001.s009.t015	(		X
es001.s009.t016	cáncer	cáncer	N
es001.s009.t017	del		X
es001.s009.t018	revestimiento	revestimiento	N
es001.s009.t019	de		X
es001.s009.t020	los		X
es001.s009.t021	pulmones	pulmón	N
es001.s009.t022	causado	causar	V
es001.s009.t023	generalmente	generalmente	R
es001.s009.t024	por		X
es001.s009.t025	la		X
es001.s009.t026	exposición	exposición	N
es001.s009.t027	al		X
es001.s009.t028	amianto	amianto	N
es001.s009.t029	)		X
es001.s009.t030	.		X
es001.s010.t001	Alimta	alimta	N
es001.s010.t002	se		X
es001.s010.t003	administra	administrar	V
es001.s010.t004	en		X
es001.s010.t005	combinación	combinación	N
es001.s010.t006	con		X
es001.s010.t007	cisplatino	cisplatino	N
es001.s010.t008	(		X
es001.s010.t009	otro		X
es001.s010.t010	medicamento	medicamento	N
es001.s010.t011	contra		X
es001.s010.t012	el		X
es001.s010.t013	cáncer	cáncer	N
es001.s010.t014	)		X
es001.s010.t015	cuando		X
es001.s010.t016	el		X
es001.s010.t017	tumor	tumor	N
es001.s010.t018	«		X
es001.s010.t019	no	no	R
es001.s010.t020	es	ser	V
es001.s010.t021	resecable	resecable	J
es001.s010.t022	»		X
es001.s010.t023	(		X
es001.s010.t024	no		X
es001.s010.t025	puede	poder	V
es001.s010.t026	extirparse	extirpar	V
es001.s010.t027	sólo	sólo	R
es001.s010.t028	mediante		X
es001.s010.t029	cirugía	cirugía	N
es001.s010.t030	)		X
es001.s010.t031	y		X
es001.s010.t032	es	ser	V
es001.s010.t033	«		X
es001.s010.t034	maligno	maligno	J
es001.s010.t035	»		X
es001.s010.t036	(		X
es001.s010.t037	se		X
es001.s010.t038	ha	haber	V
es001.s010.t039	extendido	extender	V
es001.s010.t040	,		X
es001.s010.t041	o		X
es001.s010.t042	es	ser	V
es001.s010.t043	probable	probable	J
es001.s010.t044	que		X
es001.s010.t045	se		X
es001.s010.t046	extienda	extender	V
es001.s010.t047	fácilmente	fácilmente	R
es001.s010.t048	,		X
es001.s010.t049	a		X
es001.s010.t050	otras		X
es001.s010.t051	partes	parte	N
es001.s010.t052	del		X
es001.s010.t053	cuerpo	cuerpo	N
es001.s010.t054	)		X
es001.s010.t055	,		X
es001.s010.t056	en		X
es001.s010.t057	pacientes	paciente	N
es001.s010.t058	que		X
es001.s010.t059	no	no	R
es001.s010.t060	han	haber	V
es001.s010.t061	recibido	recibir	V
es001.s010.t062	quimioterapia	quimioterapia	N
es001.s010.t063	(		X
es001.s010.t064	medicamentos	medicamento	N
es001.s010.t065	contra		X
es001.s010.t066	el		X
es001.s010.t067	cáncer	cáncer	N
es001.s010.t068	)		X
es001.s010.t069	previamente	previamente	R
es001.s010.t070	,		X
es001.s010.t071	cáncer	cáncer	N
es001.s010.t072	de		X
es001.s010.t073	pulmón	pulmón	N
es001.s010.t074	«		X
es001.s010.t075	no	no	N
es001.s010.t076	microcítico	microcito	N
es001.s010.t077	»		X
es001.s010.t078	avanzado	avanzado	J
es001.s010.t079	o		X
es001.s010.t080	metastásico	metastásico	N
es001.s010.t081	que		X
es001.s010.t082	no	no	R
es001.s010.t083	afecte	afectar	V
es001.s010.t084	a		X
es001.s010.t085	las		X
es001.s010.t086	células	célula	N
es001.s010.t087	«		X
es001.s010.t088	escamosas	escamoso	J
es001.s010.t089	»		X
es001.s010.t090	.		X
es001.s011.t001	Alimta	alimta	N
es001.s011.t002	se		X
es001.s011.t003	utiliza	utilizar	V
es001.s011.t004	en		X
es001.s011.t005	combinación	combinación	N
es001.s011.t006	con		X
es001.s011.t007	cisplatino	cisplatino	N
es001.s011.t008	en		X
es001.s011.t009	pacientes	paciente	N
es001.s011.t010	que		X
es001.s011.t011	no	no	R
es001.s011.t012	han	haber	V
es001.s011.t013	sido	ser	V
es001.s011.t014	tratados	tratar	V
es001.s011.t015	previamente	previamente	R
es001.s011.t016	y		X
es001.s011.t017	en		X
es001.s011.t018	monoterapia	monoterapia	N
es001.s011.t019	en		X
es001.s011.t020	pacientes	paciente	N
es001.s011.t021	que		X
es001.s011.t022	han	haber	V
es001.s011.t023	sido	ser	V
es001.s011.t024	tratado	tratar	V
es001.s011.t025	previamente	previamente	R
es001.s011.t026	con		X
es001.s011.t027	otros		X
es001.s011.t028	tipos	tipo	N
es001.s011.t029	de		X
es001.s011.t030	quimioterapia	quimioterapia	N
es001.s011.t031	.		X
es001.s012.t001	Este		X
es001.s012.t002	medicamento	medicamento	N
es001.s012.t003	sólo	sólo	R
es001.s012.t004	podrá	poder	V
es001.s012.t005	dispensarse	dispensar	V
es001.s012.t006	con		X
es001.s012.t007	receta	receta	N
es001.s012.t008	médica	médico	J
es001.s012.t009	.		X
es001.s013.t001	¿Cómo	¿cómo	N
es001.s013.t002	se		X
es001.s013.t003	usa	usar	V
es001.s013.t004	Alimta	alimta	N
es001.s013.t005	?		X
es001.s014.t001	Alimta	alimta	N
es001.s014.t002	sólo	sólo	R
es001.s014.t003	debe	deber	V
es001.s014.t004	administrarse	administrar	V
es001.s014.t005	bajo		X
es001.s014.t006	la		X
es001.s014.t007	supervisión	supervisión	N
es001.s014.t008	de		X
es001.s014.t009	un		X
es001.s014.t010	médico	médico	N
es001.s014.t011	cualificado	cualificar	V
es001.s014.t012	en		X
es001.s014.t013	el		X
es001.s014.t014	uso	uso	N
es001.s014.t015	de		X
es001.s014.t016	quimioterapia	quimioterapia	N
es001.s014.t017	contra		X
es001.s014.t018	el		X
es001.s014.t019	cáncer	cáncer	N
es001.s014.t020	.		X
es001.s015.t001	La		X
es001.s015.t002	dosis	dosis	N
es001.s015.t003	recomendada	recomendar	V
es001.s015.t004	de		X
es001.s015.t005	Alimta	alimta	N
es001.s015.t006	es	ser	V
es001.s015.t007	de		X
es001.s015.t008	500		X
es001.s015.t009	mg	mg	N
es001.s015.t010	por		X
es001.s015.t011	metro	metro	N
es001.s015.t012	cuadrado	cuadrado	J
es001.s015.t013	de		X
es001.s015.t014	superficie	superficie	N
es001.s015.t015	corporal	corporal	J
es001.s015.t016	(		X
es001.s015.t017	calculada	calcular	V
es001.s015.t018	a partir de		X
es001.s015.t019	la		X
es001.s015.t020	estatura	estatura	N
es001.s015.t021	y		X
es001.s015.t022	el		X
es001.s015.t023	peso	peso	N
es001.s015.t024	del		X
es001.s015.t025	paciente	paciente	N
es001.s015.t026	)		X
es001.s015.t027	.		X
es001.s016.t001	Se		X
es001.s016.t002	administra	administrar	V
es001.s016.t003	una		X
es001.s016.t004	vez	vez	N
es001.s016.t005	cada		X
es001.s016.t006	tres		X
es001.s016.t007	semanas	semana	N
es001.s016.t008	por		X
es001.s016.t009	perfusión	perfusión	N
es001.s016.t010	intravenosa	intravenoso	J
es001.s016.t011	durante		X
es001.s016.t012	10		X
es001.s016.t013	minutos	minuto	N
es001.s016.t014	.		X
es001.s017.t001	Con		X
es001.s017.t002	el		X
es001.s017.t003	fin	fin	N
es001.s017.t004	de		X
es001.s017.t005	reducir	reducir	V
es001.s017.t006	los		X
es001.s017.t007	efectos	efecto	N
es001.s017.t008	secundarios	secundario	J
es001.s017.t009	,		X
es001.s017.t010	los		X
es001.s017.t011	pacientes	paciente	N
es001.s017.t012	deben	deber	V
es001.s017.t013	recibir	recibir	V
es001.s017.t014	un		X
es001.s017.t015	corticosteroide	corticosteroide	N
es001.s017.t016	y		X
es001.s017.t017	ácido	ácido	N
es001.s017.t018	fólico	fólico	J
es001.s017.t019	(		X
es001.s017.t020	un		X
es001.s017.t021	tipo	tipo	N
es001.s017.t022	de		X
es001.s017.t023	vitamina	vitamina	N
es001.s017.t024	)		X
es001.s017.t025	,		X
es001.s017.t026	así como		X
es001.s017.t027	inyecciones	inyección	N
es001.s017.t028	de		X
es001.s017.t029	vitamina	vitamina	N
es001.s017.t030	B12		X
es001.s017.t031	durante		X
es001.s017.t032	el		X
es001.s017.t033	tratamiento	tratamiento	N
es001.s017.t034	con		X
es001.s017.t035	Alimta	alimta	N
es001.s017.t036	.		X
es001.s018.t001	Cuando		X
es001.s018.t002	Alimta	alimta	N
es001.s018.t003	se		X
es001.s018.t004	utiliza	utilizar	V
es001.s018.t005	conjuntamente	conjuntamente	R
es001.s018.t006	con		X
es001.s018.t007	cisplatino	cisplatino	N
es001.s018.t008	,		X
es001.s018.t009	hay que	haber~que	V
es001.s018.t010	administrar	administrar	V
es001.s018.t011	además	además	R
es001.s018.t012	un		X
es001.s018.t013	medicamento	medicamento	N
es001.s018.t014	«		X
es001.s018.t015	antiemético	antiemético	N
es001.s018.t016	»		X
es001.s018.t017	(		X
es001.s018.t018	para		X
es001.s018.t019	evitar	evitar	V
es001.s018.t020	los		X
es001.s018.t021	vómitos	vómito	N
es001.s018.t022	)		X
es001.s018.t023	y		X
es001.s018.t024	líquidos	líquido	N
es001.s018.t025	(		X
es001.s018.t026	para		X
es001.s018.t027	evitar	evitar	V
es001.s018.t028	la		X
es001.s018.t029	deshidratación	deshidratación	N
es001.s018.t030	)		X
es001.s018.t031	antes		X
es001.s018.t032	o		X
es001.s018.t033	después de		X
es001.s018.t034	la		X
es001.s018.t035	dosis	dosis	N
es001.s018.t036	de		X
es001.s018.t037	cisplatino	cisplatino	N
es001.s018.t038	.		X
es001.s019.t001	Será	ser	V
es001.s019.t002	necesario	necesario	J
es001.s019.t003	retrasar	retrasar	V
es001.s019.t004	o		X
es001.s019.t005	suspender	suspender	V
es001.s019.t006	el		X
es001.s019.t007	tratamiento	tratamiento	N
es001.s019.t008	,		X
es001.s019.t009	o		X
es001.s019.t010	reducir	reducir	V
es001.s019.t011	la		X
es001.s019.t012	dosis	dosis	N
es001.s019.t013	,		X
es001.s019.t014	en		X
es001.s019.t015	pacientes	paciente	N
es001.s019.t016	que		X
es001.s019.t017	presenten	presentar	V
es001.s019.t018	alteraciones	alteración	N
es001.s019.t019	en		X
es001.s019.t020	los		X
es001.s019.t021	recuentos	recuento	N
es001.s019.t022	sanguíneos	sanguíneo	J
es001.s019.t023	o		X
es001.s019.t024	determinados	determinado	J
es001.s019.t025	efectos	efecto	N
es001.s019.t026	secundarios	secundario	J
es001.s019.t027	.		X
es001.s020.t001	No	no	R
es001.s020.t002	se		X
es001.s020.t003	recomienda	recomendar	V
es001.s020.t004	administrar	administrar	V
es001.s020.t005	Alimta	alimta	N
es001.s020.t006	a		X
es001.s020.t007	pacientes	paciente	N
es001.s020.t008	con		X
es001.s020.t009	problemas	problema	N
es001.s020.t010	renales	renal	J
es001.s020.t011	moderados	moderado	J
es001.s020.t012	o		X
es001.s020.t013	graves	grave	J
es001.s020.t014	.		X
es001.s021.t001	Si		X
es001.s021.t002	desea	desear	V
es001.s021.t003	más	más	R
es001.s021.t004	información	información	N
es001.s021.t005	,		X
es001.s021.t006	consulte	consultar	V
es001.s021.t007	el		X
es001.s021.t008	Resumen	resumen	N
es001.s021.t009	de		X
es001.s021.t010	las		X
es001.s021.t011	Características	característica	N
es001.s021.t012	del		X
es001.s021.t013	Producto	producto	N
es001.s021.t014	,		X
es001.s021.t015	que		X
es001.s021.t016	también	también	R
es001.s021.t017	forma	formar	V
es001.s021.t018	parte	parte	N
es001.s021.t019	del		X
es001.s021.t020	EPAR	epar	N
es001.s021.t021	.		X
es001.s022.t001	¿Cómo	cómo	R
es001.s022.t002	actúa	actuar	V
es001.s022.t003	Alimta	alimta	N
es001.s022.t004	?		X
es001.s023.t001	El		X
es001.s023.t002	principio	principio	N
es001.s023.t003	activo	activo	J
es001.s023.t004	de		X
es001.s023.t005	Alimta	alimta	N
es001.s023.t006	,		X
es001.s023.t007	el		X
es001.s023.t008	pemetrexed	pemetrexed	N
es001.s023.t009	,		X
es001.s023.t010	es	ser	V
es001.s023.t011	un		X
es001.s023.t012	medicamento	medicamento	N
es001.s023.t013	citotóxico	citotóxico	N
es001.s023.t014	(		X
es001.s023.t015	un		X
es001.s023.t016	medicamento	medicamento	N
es001.s023.t017	que		X
es001.s023.t018	destruye	destruir	V
es001.s023.t019	las		X
es001.s023.t020	células	célula	N
es001.s023.t021	que		X
es001.s023.t022	están	estar	V
es001.s023.t023	en		X
es001.s023.t024	fase	fase	N
es001.s023.t025	de		X
es001.s023.t026	división	división	N
es001.s023.t027	,		X
es001.s023.t028	como		X
es001.s023.t029	las		X
es001.s023.t030	cancerosas	canceroso	J
es001.s023.t031	)		X
es001.s023.t032	que		X
es001.s023.t033	pertenece	pertenecer	V
es001.s023.t034	al		X
es001.s023.t035	grupo	grupo	N
es001.s023.t036	de		X
es001.s023.t037	los		X
es001.s023.t038	«		X
es001.s023.t039	antimetabolitos	antimetabolitos	N
es001.s023.t040	»		X
es001.s023.t041	.		X
es001.s024.t001	En		X
es001.s024.t002	el		X
es001.s024.t003	organismo	organismo	N
es001.s024.t004	,		X
es001.s024.t005	el		X
es001.s024.t006	pemetrexed	pemetrexed	N
es001.s024.t007	se		X
es001.s024.t008	convierte	convertir	V
es001.s024.t009	en		X
es001.s024.t010	una		X
es001.s024.t011	forma	forma	N
es001.s024.t012	activa	activo	J
es001.s024.t013	que		X
es001.s024.t014	bloquea	bloquear	V
es001.s024.t015	la		X
es001.s024.t016	actividad	actividad	N
es001.s024.t017	de		X
es001.s024.t018	las		X
es001.s024.t019	enzimas	enzima	N
es001.s024.t020	que		X
es001.s024.t021	participan	participar	V
es001.s024.t022	en		X
es001.s024.t023	la		X
es001.s024.t024	producción	producción	N
es001.s024.t025	de		X
es001.s024.t026	«		X
es001.s024.t027	nucleótidos	nucleótido	N
es001.s024.t028	»		X
es001.s024.t029	(		X
es001.s024.t030	elementos	elemento	N
es001.s024.t031	esenciales	esencial	J
es001.s024.t032	del		X
es001.s024.t033	ADN	adn	N
es001.s024.t034	y		X
es001.s024.t035	el		X
es001.s024.t036	ARN	arn	N
es001.s024.t037	,		X
es001.s024.t038	el		X
es001.s024.t039	material	material	N
es001.s024.t040	genético	genético	J
es001.s024.t041	de		X
es001.s024.t042	las		X
es001.s024.t043	células	célula	N
es001.s024.t044	)		X
es001.s024.t045	.		X
es001.s025.t001	¿Qué	qué	J
es001.s025.t002	tipo	tipo	N
es001.s025.t003	de		X
es001.s025.t004	estudios	estudio	N
es001.s025.t005	se		X
es001.s025.t006	han	haber	V
es001.s025.t007	realizado	realizar	V
es001.s025.t008	con		X
es001.s025.t009	Alimta	alimta	N
es001.s025.t010	?		X
es001.s026.t001	Por		X
es001.s026.t002	lo		X
es001.s026.t003	que		X
es001.s026.t004	se		X
es001.s026.t005	refiere	referir	V
es001.s026.t006	al		X
es001.s026.t007	tratamiento	tratamiento	N
es001.s026.t008	del		X
es001.s026.t009	mesotelioma	mesotelioma	N
es001.s026.t010	pleural	pleural	J
es001.s026.t011	maligno	maligno	J
es001.s026.t012	,		X
es001.s026.t013	Alimta	alimta	N
es001.s026.t014	ha	haber	V
es001.s026.t015	sido	ser	V
es001.s026.t016	evaluado	evaluar	V
es001.s026.t017	en		X
es001.s026.t018	un		X
es001.s026.t019	estudio	estudio	N
es001.s026.t020	principal	principal	J
es001.s026.t021	realizado	realizar	V
es001.s026.t022	en		X
es001.s026.t023	456		X
es001.s026.t024	pacientes	paciente	N
es001.s026.t025	que		X
es001.s026.t026	no	no	R
es001.s026.t027	habían	haber	V
es001.s026.t028	recibido	recibir	V
es001.s026.t029	quimioterapia	quimioterapia	N
es001.s026.t030	anteriormente	anteriormente	R
es001.s026.t031	.		X
es001.s027.t001	Se		X
es001.s027.t002	compararon	comparar	V
es001.s027.t003	los		X
es001.s027.t004	efectos	efecto	N
es001.s027.t005	de		X
es001.s027.t006	Alimta	alimta	N
es001.s027.t007	en		X
es001.s027.t008	combinación	combinación	N
es001.s027.t009	con		X
es001.s027.t010	cisplatino	cisplatino	N
es001.s027.t011	con		X
es001.s027.t012	los		X
es001.s027.t013	efectos	efecto	N
es001.s027.t014	del		X
es001.s027.t015	cisplatino	cisplatino	N
es001.s027.t016	administrado	administrar	V
es001.s027.t017	en		X
es001.s027.t018	solitario	solitario	J
es001.s027.t019	.		X
es001.s028.t001	En		X
es001.s028.t002	cuanto		X
es001.s028.t003	al		X
es001.s028.t004	tratamiento	tratamiento	N
es001.s028.t005	del		X
es001.s028.t006	cáncer	cáncer	N
es001.s028.t007	de		X
es001.s028.t008	pulmón	pulmón	N
es001.s028.t009	no	no	N
es001.s028.t010	microcítico	microcito	N
es001.s028.t011	,		X
es001.s028.t012	se		X
es001.s028.t013	compararon	comparar	V
es001.s028.t014	los		X
es001.s028.t015	efectos	efecto	N
es001.s028.t016	de		X
es001.s028.t017	Alimta	alimta	N
es001.s028.t018	con		X
es001.s028.t019	los		X
es001.s028.t020	del		X
es001.s028.t021	docetaxel	docetaxel	N
es001.s028.t022	(		X
es001.s028.t023	otro		X
es001.s028.t024	medicamento	medicamento	N
es001.s028.t025	contra		X
es001.s028.t026	el		X
es001.s028.t027	cáncer	cáncer	N
es001.s028.t028	)		X
es001.s028.t029	en		X
es001.s028.t030	un		X
es001.s028.t031	estudio	estudio	N
es001.s028.t032	realizado	realizar	V
es001.s028.t033	en		X
es001.s028.t034	571		X
es001.s028.t035	pacientes	paciente	N
es001.s028.t036	con		X
es001.s028.t037	enfermedad	enfermedad	N
es001.s028.t038	localmente	localmente	R
es001.s028.t039	avanzada	avanzar	V
es001.s028.t040	o		X
es001.s028.t041	metastásica	metastásico	N
es001.s028.t042	que		X
es001.s028.t043	habían	haber	V
es001.s028.t044	recibido	recibir	V
es001.s028.t045	quimioterapia	quimioterapia	N
es001.s028.t046	previamente	previamente	R
es001.s028.t047	.		X
es001.s029.t001	Alimta	alimta	N
es001.s029.t002	también	también	R
es001.s029.t003	se		X
es001.s029.t004	comparó	comparar	V
es001.s029.t005	con		X
es001.s029.t006	gemcitabina	gemcitabina	N
es001.s029.t007	(		X
es001.s029.t008	otro		X
es001.s029.t009	medicamento	medicamento	N
es001.s029.t010	contra		X
es001.s029.t011	el		X
es001.s029.t012	cáncer	cáncer	N
es001.s029.t013	)		X
es001.s029.t014	,		X
es001.s029.t015	ambos		X
es001.s029.t016	en		X
es001.s029.t017	combinación	combinación	N
es001.s029.t018	con		X
es001.s029.t019	cisplatino	cisplatino	N
es001.s029.t020	,		X
es001.s029.t021	en		X
es001.s029.t022	un		X
es001.s029.t023	estudio	estudio	N
es001.s029.t024	con		X
es001.s029.t025	1.725		X
es001.s029.t026	pacientes	paciente	N
es001.s029.t027	que		X
es001.s029.t028	no	no	N
es001.s029.t029	habían	haber	V
es001.s029.t030	recibido	recibir	V
es001.s029.t031	quimioterapia	quimioterapia	N
es001.s029.t032	contra		X
es001.s029.t033	el		X
es001.s029.t034	cáncer	cáncer	N
es001.s029.t035	de		X
es001.s029.t036	pulmón	pulmón	N
es001.s029.t037	previamente	previamente	R
es001.s029.t038	.		X
es001.s030.t001	En		X
es001.s030.t002	los		X
es001.s030.t003	tres		X
es001.s030.t004	estudios	estudio	N
es001.s030.t005	,		X
es001.s030.t006	el		X
es001.s030.t007	criterio	criterio	N
es001.s030.t008	principal	principal	J
es001.s030.t009	de		X
es001.s030.t010	valoración	valoración	N
es001.s030.t011	de		X
es001.s030.t012	la		X
es001.s030.t013	eficacia	eficacia	N
es001.s030.t014	fue	ser	V
es001.s030.t015	el		X
es001.s030.t016	tiempo	tiempo	N
es001.s030.t017	de		X
es001.s030.t018	supervivencia	supervivencia	N
es001.s030.t019	de		X
es001.s030.t020	los		X
es001.s030.t021	pacientes	paciente	N
es001.s030.t022	.		X
es001.s031.t001	¿Qué	¿qué	N
es001.s031.t002	beneficio	beneficio	N
es001.s031.t003	ha	haber	V
es001.s031.t004	demostrado	demostrar	V
es001.s031.t005	tener	tener	V
es001.s031.t006	Alimta	alimta	N
es001.s031.t007	durante		X
es001.s031.t008	los		X
es001.s031.t009	estudios	estudio	N
es001.s031.t010	?		X
es001.s032.t001	Alimta	alimta	N
es001.s032.t002	prolongó	prolongar	V
es001.s032.t003	el		X
es001.s032.t004	tiempo	tiempo	N
es001.s032.t005	de		X
es001.s032.t006	supervivencia	supervivencia	N
es001.s032.t007	de		X
es001.s032.t008	los		X
es001.s032.t009	pacientes	paciente	N
es001.s032.t010	con		X
es001.s032.t011	mesotelioma	mesotelioma	N
es001.s032.t012	pleural	pleural	J
es001.s032.t013	maligno	maligno	J
es001.s032.t014	.		X
es001.s033.t001	Los		X
es001.s033.t002	pacientes	paciente	N
es001.s033.t003	que		X
es001.s033.t004	recibieron	recibir	V
es001.s033.t005	Alimta	alimta	N
es001.s033.t006	y		X
es001.s033.t007	cisplatino	cisplatino	N
es001.s033.t008	sobrevivieron	sobrevivir	V
es001.s033.t009	una		X
es001.s033.t010	media	media	N
es001.s033.t011	de		X
es001.s033.t012	12,1		X
es001.s033.t013	meses	mes	N
es001.s033.t014	,		X
es001.s033.t015	mientras que		X
es001.s033.t016	la		X
es001.s033.t017	supervivencia	supervivencia	N
es001.s033.t018	de		X
es001.s033.t019	los		X
es001.s033.t020	enfermos	enfermo	N
es001.s033.t021	tratados	tratar	V
es001.s033.t022	sólo	sólo	R
es001.s033.t023	con		X
es001.s033.t024	cisplatino	cisplatino	N
es001.s033.t025	fue	ser	V
es001.s033.t026	de		X
es001.s033.t027	9,3		X
es001.s033.t028	meses	mes	N
es001.s033.t029	.		X
es001.s034.t001	En		X
es001.s034.t002	el		X
es001.s034.t003	tratamiento	tratamiento	N
es001.s034.t004	de		X
es001.s034.t005	pacientes	paciente	N
es001.s034.t006	con		X
es001.s034.t007	cáncer	cáncer	N
es001.s034.t008	de		X
es001.s034.t009	pulmón	pulmón	N
es001.s034.t010	no	no	N
es001.s034.t011	microcítico	microcito	N
es001.s034.t012	,		X
es001.s034.t013	Alimta	alimta	N
es001.s034.t014	fue	ser	V
es001.s034.t015	tan	tan	R
es001.s034.t016	efectivo	efectivo	J
es001.s034.t017	como		X
es001.s034.t018	los		X
es001.s034.t019	medicamentos	medicamento	N
es001.s034.t020	de		X
es001.s034.t021	comparación	comparación	N
es001.s034.t022	.		X
es001.s035.t001	En		X
es001.s035.t002	los		X
es001.s035.t003	pacientes	paciente	N
es001.s035.t004	que		X
es001.s035.t005	habían	haber	V
es001.s035.t006	recibido	recibir	V
es001.s035.t007	quimioterapia	quimioterapia	N
es001.s035.t008	previamente	previamente	R
es001.s035.t009	,		X
es001.s035.t010	el		X
es001.s035.t011	tiempo	tiempo	N
es001.s035.t012	medio	medio	J
es001.s035.t013	de		X
es001.s035.t014	supervivencia	supervivencia	N
es001.s035.t015	fue	ser	V
es001.s035.t016	de		X
es001.s035.t017	8,3		X
es001.s035.t018	meses	mes	N
es001.s035.t019	con		X
es001.s035.t020	Alimta	alimta	N
es001.s035.t021	frente a		X
es001.s035.t022	7,9		X
es001.s035.t023	meses	mes	N
es001.s035.t024	con		X
es001.s035.t025	docetaxel	docetaxel	N
es001.s035.t026	.		X
es001.s036.t001	En		X
es001.s036.t002	pacientes	paciente	N
es001.s036.t003	que		X
es001.s036.t004	no	no	N
es001.s036.t005	habían	haber	V
es001.s036.t006	recibido	recibir	V
es001.s036.t007	previamente	previamente	R
es001.s036.t008	quimioterapia	quimioterapia	N
es001.s036.t009	,		X
es001.s036.t010	el		X
es001.s036.t011	tiempo	tiempo	N
es001.s036.t012	medio	medio	J
es001.s036.t013	de		X
es001.s036.t014	supervivencia	supervivencia	N
es001.s036.t015	fue	ser	V
es001.s036.t016	de		X
es001.s036.t017	10,3		X
es001.s036.t018	meses	mes	N
es001.s036.t019	en		X
es001.s036.t020	ambos		X
es001.s036.t021	grupos	grupo	N
es001.s036.t022	.		X
es001.s037.t001	No obstante	no~obstante	R
es001.s037.t002	,		X
es001.s037.t003	los		X
es001.s037.t004	pacientes	paciente	N
es001.s037.t005	de		X
es001.s037.t006	ambos		X
es001.s037.t007	estudios	estudio	N
es001.s037.t008	cuyo		X
es001.s037.t009	cáncer	cáncer	N
es001.s037.t010	no	no	N
es001.s037.t011	afectaba	afectar	V
es001.s037.t012	a		X
es001.s037.t013	las		X
es001.s037.t014	células	célula	N
es001.s037.t015	escamosas	escamosas	J
es001.s037.t016	presentaban	presentar	V
es001.s037.t017	un		X
es001.s037.t018	mayor	grande	J
es001.s037.t019	tiempo	tiempo	N
es001.s037.t020	de		X
es001.s037.t021	supervivencia	supervivencia	N
es001.s037.t022	cuando		X
es001.s037.t023	recibían	recibir	V
es001.s037.t024	Alimta	alimta	N
es001.s037.t025	que		X
es001.s037.t026	cuando		X
es001.s037.t027	recibían	recibir	V
es001.s037.t028	el		X
es001.s037.t029	medicamento	medicamento	N
es001.s037.t030	de		X
es001.s037.t031	comparación	comparación	N
es001.s037.t032	.		X
es002.s001.t001	kalgebra	kalgebra	N
es002.s001.t002	es	ser	V
es002.s001.t003	una		X
es002.s001.t004	calculadora	calculadora	N
es002.s001.t005	matemática	matemático	J
es002.s001.t006	basada	basar	V
es002.s001.t007	en		X
es002.s001.t008	el		X
es002.s001.t009	lenguaje	lenguaje	N
es002.s001.t010	de		X
es002.s001.t011	marcado	marcado	N
es002.s001.t012	MathML	mathml	N
es002.s001.t013	.		X
es002.s002.t001	Hoy	hoy	R
es002.s002.t002	en		X
es002.s002.t003	día	día	N
es002.s002.t004	es	ser	V
es002.s002.t005	capaz	capaz	J
es002.s002.t006	de		X
es002.s002.t007	realizar	realizar	V
es002.s002.t008	operaciones	operación	N
es002.s002.t009	simples	simple	J
es002.s002.t010	(		X
es002.s002.t011	aritméticas	aritmético	J
es002.s002.t012	y		X
es002.s002.t013	lógicas	lógico	J
es002.s002.t014	)		X
es002.s002.t015	usando	usar	V
es002.s002.t016	MathML	mathml	N
es002.s002.t017	y		X
es002.s002.t018	de		X
es002.s002.t019	representarlas	representar	V
es002.s002.t020	en		X
es002.s002.t021	gráficas	gráfica	N
es002.s002.t022	de		X
es002.s002.t023	dos		X
es002.s002.t024	y		X
es002.s002.t025	tres		X
es002.s002.t026	dimensiones	dimensión	N
es002.s002.t027	.		X
es002.s003.t001	No	no	N
es002.s003.t002	es	ser	V
es002.s003.t003	necesario	necesario	J
es002.s003.t004	conocer	conocer	V
es002.s003.t005	MathML	mathml	N
es002.s003.t006	para		X
es002.s003.t007	usar	usar	V
es002.s003.t008	kalgebra	kalgebra	N
es002.s003.t009	.		X
es002.s004.t001	kalgebra	kalgebra	N
es002.s004.t002	es	ser	V
es002.s004.t003	una		X
es002.s004.t004	calculadora	calculadora	N
es002.s004.t005	gráfica	gráfico	J
es002.s004.t006	basada	basar	V
es002.s004.t007	en		X
es002.s004.t008	MathML	mathml	N
es002.s004.t009	.		X
es002.s005.t001	Aunque		X
es002.s005.t002	en		X
es002.s005.t003	un		X
es002.s005.t004	principio	principio	N
es002.s005.t005	estuvo	estar	V
es002.s005.t006	orientado	orientar	V
es002.s005.t007	a		X
es002.s005.t008	MathML	mathml	N
es002.s005.t009	,		X
es002.s005.t010	actualmente	actualmente	R
es002.s005.t011	puede	poder	V
es002.s005.t012	ser	ser	V
es002.s005.t013	usado	usar	V
es002.s005.t014	por		X
es002.s005.t015	cualquier		X
es002.s005.t016	persona	persona	N
es002.s005.t017	,		X
es002.s005.t018	aunque		X
es002.s005.t019	posea	poseer	V
es002.s005.t020	pocos		X
es002.s005.t021	conocimientos	conocimiento	N
es002.s005.t022	matemáticos	matemático	J
es002.s005.t023	.		X
es002.s006.t001	Aquí	aquí	R
es002.s006.t002	se		X
es002.s006.t003	muestra	mostrar	V
es002.s006.t004	una		X
es002.s006.t005	captura	captura	N
es002.s006.t006	de		X
es002.s006.t007	la		X
es002.s006.t008	ventana	ventana	N
es002.s006.t009	principal	principal	J
es002.s006.t010	de		X
es002.s006.t011	kalgebra	kalgebra	N
es002.s006.t012	.		X
es002.s007.t001	Ventana	ventana	N
es002.s007.t002	principal	principal	J
es002.s007.t003	de		X
es002.s007.t004	kalgebra	kalgebra	N
es002.s008.t001	La		X
es002.s008.t002	ventana	ventana	N
es002.s008.t003	principal	principal	J
es002.s008.t004	de		X
es002.s008.t005	kalgebra	kalgebra	N
es002.s008.t006	consta	constar	V
es002.s008.t007	de		X
es002.s008.t008	cuatro		X
es002.s008.t009	pestañas	pestaña	N
es002.s008.t010	:		X
es002.s008.t011	Consola	consola	N
es002.s008.t012	,		X
es002.s008.t013	Gráfica	gráfica	N
es002.s008.t014	2D	2d	N
es002.s008.t015	,		X
es002.s008.t016	Gráfica	gráfica	N
es002.s008.t017	3D	3d	N
es002.s008.t018	y		X
es002.s008.t019	Diccionario	diccionario	N
es002.s008.t020	.		X
es002.s009.t001	Bajo		X
es002.s009.t002	estas		X
es002.s009.t003	pestañas	pestaña	N
es002.s009.t004	encontrará	encontrar	V
es002.s009.t005	un		X
es002.s009.t006	campo	campo	N
es002.s009.t007	de		X
es002.s009.t008	entrada	entrada	N
es002.s009.t009	donde	donde	R
es002.s009.t010	podrá	poder	V
es002.s009.t011	introducir	introducir	V
es002.s009.t012	sus		X
es002.s009.t013	funciones	función	N
es002.s009.t014	o		X
es002.s009.t015	realizar	realizar	V
es002.s009.t016	sus		X
es002.s009.t017	cálculos	cálculo	N
es002.s009.t018	.		X
es002.s010.t001	Para		X
es002.s010.t002	entender	entender	V
es002.s010.t003	cómo	cómo	R
es002.s010.t004	funciona	funcionar	V
es002.s010.t005	,		X
es002.s010.t006	conviene	convenir	V
es002.s010.t007	comprender	comprender	V
es002.s010.t008	que		X
es002.s010.t009	lo		X
es002.s010.t010	que		X
es002.s010.t011	introducimos	introducir	V
es002.s010.t012	está	estar	V
es002.s010.t013	siendo	ser	V
es002.s010.t014	convertido	convertir	V
es002.s010.t015	a		X
es002.s010.t016	MathML	mathml	N
es002.s010.t017	,		X
es002.s010.t018	aunque		X
es002.s010.t019	no	no	N
es002.s010.t020	es	ser	V
es002.s010.t021	necesario	necesario	J
es002.s010.t022	conocer	conocer	V
es002.s010.t023	MathML	mathml	N
es002.s010.t024	.		X
es002.s011.t001	He	haber	V
es002.s011.t002	basado	basar	V
es002.s011.t003	la		X
es002.s011.t004	sintaxis	sintaxis	N
es002.s011.t005	en		X
es002.s011.t006	el		X
es002.s011.t007	sentido	sentido	N
es002.s011.t008	común	común	J
es002.s011.t009	,		X
es002.s011.t010	por		X
es002.s011.t011	lo		X
es002.s011.t012	que		X
es002.s011.t013	debería	deber	V
es002.s011.t014	ser	ser	V
es002.s011.t015	asequible	asequible	J
es002.s011.t016	para		X
es002.s011.t017	todos		X
es002.s011.t018	.		X
es002.s012.t001	He	haber	V
es002.s012.t002	tenido	tener	V
es002.s012.t003	también	también	R
es002.s012.t004	en		X
es002.s012.t005	cuenta	cuenta	N
es002.s012.t006	las		X
es002.s012.t007	sintaxis	sintaxis	N
es002.s012.t008	de		X
es002.s012.t009	Maxima	maxima	N
es002.s012.t010	y		X
es002.s012.t011	Maple	maple	N
es002.s012.t012	,		X
es002.s012.t013	por		X
es002.s012.t014	lo		X
es002.s012.t015	que		X
es002.s012.t016	es	ser	V
es002.s012.t017	muy	muy	R
es002.s012.t018	similar	similar	J
es002.s012.t019	a		X
es002.s012.t020	estas		X
es002.s012.t021	.		X
es002.s013.t001	+		X
es002.s013.t002	-		X
es002.s013.t003	*		X
es002.s013.t004	/		X
es002.s013.t005	:		X
es002.s013.t006	suma	suma	N
es002.s013.t007	,		X
es002.s013.t008	resta	resta	N
es002.s013.t009	,		X
es002.s013.t010	multiplicación	multiplicación	N
es002.s013.t011	y		X
es002.s013.t012	división	división	N
es002.s013.t013	.		X
es002.s014.t001	^		X
es002.s014.t002	,		X
es002.s014.t003	**	**	V
es002.s014.t004	:		X
es002.s014.t005	potencia	potencia	N
es002.s014.t006	,		X
es002.s014.t007	puede	poder	V
es002.s014.t008	usar	usar	V
es002.s014.t009	cualquiera		X
es002.s014.t010	de		X
es002.s014.t011	las		X
es002.s014.t012	dos		X
es002.s014.t013	formas	forma	N
es002.s014.t014	.		X
es002.s015.t001	Asimismo	asimismo	R
es002.s015.t002	,		X
es002.s015.t003	puede	poder	V
es002.s015.t004	usar	usar	V
es002.s015.t005	los		X
es002.s015.t006	caracteres	carácter	N
es002.s015.t007	unicode	unicode	N
es002.s015.t008	²		X
es002.s015.t009	.		X
es002.s016.t001	Las		X
es002.s016.t002	potencias	potencia	N
es002.s016.t003	son	ser	V
es002.s016.t004	también	también	R
es002.s016.t005	una		X
es002.s016.t006	forma	forma	N
es002.s016.t007	de		X
es002.s016.t008	expresar	expresar	V
es002.s016.t009	raíces	raíz	N
es002.s016.t010	.		X
es002.s017.t001	-gt		X
es002.s017.t002	:		X
es002.s017.t003	Permite	permitir	V
es002.s017.t004	especificar	especificar	V
es002.s017.t005	la		X
es002.s017.t006	variable	variable	N
es002.s017.t007	limitada	limitar	V
es002.s017.t008	en		X
es002.s017.t009	una		X
es002.s017.t010	función	función	N
es002.s017.t011	.		X
es002.s018.t001	(		X
es002.s018.t002	)		X
es002.s018.t003	:		X
es002.s018.t004	se		X
es002.s018.t005	usa	usar	V
es002.s018.t006	para		X
es002.s018.t007	especificar	especificar	V
es002.s018.t008	una		X
es002.s018.t009	prioridad	prioridad	N
es002.s018.t010	mayor	grande	J
es002.s018.t011	.		X
es002.s019.t001	abc(parámetros)		X
es002.s019.t002	:		X
es002.s019.t003	Cuando		X
es002.s019.t004	el		X
es002.s019.t005	analizador	analizador	N
es002.s019.t006	sintáctico	sintáctico	J
es002.s019.t007	encuentra	encontrar	V
es002.s019.t008	una		X
es002.s019.t009	función	función	N
es002.s019.t010	,		X
es002.s019.t011	comprueba	comprobar	V
es002.s019.t012	si		X
es002.s019.t013	«		X
es002.s019.t014	abc	abc	N
es002.s019.t015	»		X
es002.s019.t016	es	ser	V
es002.s019.t017	un		X
es002.s019.t018	operador	operador	N
es002.s019.t019	.		X
es002.s020.t001	Si		X
es002.s020.t002	lo		X
es002.s020.t003	es	ser	V
es002.s020.t004	,		X
es002.s020.t005	lo		X
es002.s020.t006	trata	tratar	V
es002.s020.t007	como		X
es002.s020.t008	un		X
es002.s020.t009	operador	operador	N
es002.s020.t010	si		X
es002.s020.t011	no	no	N
es002.s020.t012	lo		X
es002.s020.t013	es	ser	V
es002.s020.t014	,		X
es002.s020.t015	lo		X
es002.s020.t016	trata	tratar	V
es002.s020.t017	como		X
es002.s020.t018	una		X
es002.s020.t019	función	función	N
es002.s020.t020	de		X
es002.s020.t021	usuario	usuario	N
es002.s020.t022	.		X
es002.s021.t001	:		X
es002.s021.t002	=		X
es002.s021.t003	:		X
es002.s021.t004	Se		X
es002.s021.t005	usa	usar	V
es002.s021.t006	para		X
es002.s021.t007	definir	definir	V
es002.s021.t008	el		X
es002.s021.t009	valor	valor	N
es002.s021.t010	de		X
es002.s021.t011	una		X
es002.s021.t012	variable	variable	N
es002.s021.t013	.		X
es002.s022.t001	?		X
es002.s022.t002	:		X
es002.s022.t003	definición	definición	N
es002.s022.t004	de		X
es002.s022.t005	condiciones	condición	N
es002.s022.t006	en		X
es002.s022.t007	funciones	función	N
es002.s022.t008	definidas	definir	V
es002.s022.t009	a		X
es002.s022.t010	trozos	trozo	N
es002.s022.t011	(		X
es002.s022.t012	«		X
es002.s022.t013	piecewise	piecewise	N
es002.s022.t014	»		X
es002.s022.t015	)		X
es002.s022.t016	.		X
es002.s023.t001	Permite	permitir	V
es002.s023.t002	definir	definir	V
es002.s023.t003	operaciones	operación	N
es002.s023.t004	condicionales	condicional	J
es002.s023.t005	en		X
es002.s023.t006	kalgebra	kalgebra	N
es002.s023.t007	.		X
es002.s024.t001	Cuando		X
es002.s024.t002	introducimos	introducimos	V
es002.s024.t003	la		X
es002.s024.t004	condición	condición	N
es002.s024.t005	antes		X
es002.s024.t006	del		X
es002.s024.t007	símbolo	símbolo	N
es002.s024.t008	«		X
es002.s024.t009	?		X
es002.s024.t010	»		X
es002.s024.t011	,		X
es002.s024.t012	kalgebra	kalgebra	N
es002.s024.t013	utiliza	utilizar	V
es002.s024.t014	esta		X
es002.s024.t015	condición	condición	N
es002.s024.t016	solo	solo	R
es002.s024.t017	si		X
es002.s024.t018	es	ser	V
es002.s024.t019	verdadera	verdadero	J
es002.s024.t020	en cambio	en~cambio	R
es002.s024.t021	,		X
es002.s024.t022	si		X
es002.s024.t023	encuentra	encontrar	V
es002.s024.t024	un		X
es002.s024.t025	símbolo	símbolo	N
es002.s024.t026	«		X
es002.s024.t027	?		X
es002.s024.t028	»		X
es002.s024.t029	sin		X
es002.s024.t030	ninguna		X
es002.s024.t031	condición	condición	N
es002.s024.t032	,		X
es002.s024.t033	toma	tomar	V
es002.s024.t034	en		X
es002.s024.t035	cuenta	cuenta	N
es002.s024.t036	el		X
es002.s024.t037	último	último	J
es002.s024.t038	caso	caso	N
es002.s024.t039	.		X
es002.s025.t001	{		X
es002.s025.t002	}		X
es002.s025.t003	:		X
es002.s025.t004	Puede	poder	V
es002.s025.t005	usarse	usar	V
es002.s025.t006	para		X
es002.s025.t007	definir	definir	V
es002.s025.t008	un		X
es002.s025.t009	contenedor	contenedor	N
es002.s025.t010	.		X
es002.s026.t001	Es	ser	V
es002.s026.t002	muy	muy	R
es002.s026.t003	útil	útil	J
es002.s026.t004	a		X
es002.s026.t005	la		X
es002.s026.t006	hora	hora	N
es002.s026.t007	de		X
es002.s026.t008	trabajar	trabajar	V
es002.s026.t009	con		X
es002.s026.t010	funciones	función	N
es002.s026.t011	definidas	definir	V
es002.s026.t012	a		X
es002.s026.t013	trozos	trozo	N
es002.s026.t014	.		X
es002.s027.t001	Ahora	ahora	R
es002.s027.t002	puede	poder	V
es002.s027.t003	preguntarme	preguntar	V
es002.s027.t004	por qué	por~qué	R
es002.s027.t005	debería	deber	V
es002.s027.t006	el		X
es002.s027.t007	usuario	usuario	N
es002.s027.t008	preocuparse	preocupar	V
es002.s027.t009	por		X
es002.s027.t010	MathML	mathml	N
es002.s027.t011	.		X
es002.s028.t001	La		X
es002.s028.t002	respuesta	respuesta	N
es002.s028.t003	es	ser	V
es002.s028.t004	fácil	fácil	J
es002.s028.t005	.		X
es002.s028.t006	Con		X
es002.s028.t007	esto		X
es002.s028.t008	podremos	poder	V
es002.s028.t009	realizar	realizar	V
es002.s028.t010	operaciones	operación	N
es002.s028.t011	con		X
es002.s028.t012	funciones	función	N
es002.s028.t013	como		X
es002.s028.t014	cos()	cos	N
es002.s028.t015	,		X
es002.s028.t016	sin()	sin	N
es002.s028.t017	(		X
es002.s028.t018	o		X
es002.s028.t019	cualquier		X
es002.s028.t020	otra		X
es002.s028.t021	función	función	N
es002.s028.t022	trigonométrica	trigonométrica	J
es002.s028.t023	)		X
es002.s028.t024	,		X
es002.s028.t025	sum()	sum	N
es002.s028.t026	o		X
es002.s028.t027	product()	product	N
es002.s028.t028	.		X
es002.s029.t001	No	no	N
es002.s029.t002	importa	importar	V
es002.s029.t003	el		X
es002.s029.t004	tipo	tipo	N
es002.s029.t005	de		X
es002.s029.t006	función	función	N
es002.s029.t007	que		X
es002.s029.t008	sea	ser	V
es002.s029.t009	.		X
es002.s030.t001	Podremos	poder	V
es002.s030.t002	usar	usar	V
es002.s030.t003	plus()	plus	N
es002.s030.t004	,		X
es002.s030.t005	times()	times	N
es002.s030.t006	y		X
es002.s030.t007	cualquier		X
es002.s030.t008	cosa	cosa	N
es002.s030.t009	a la que		X
es002.s030.t010	le		X
es002.s030.t011	corresponda	corresponder	V
es002.s030.t012	un		X
es002.s030.t013	operador	operador	N
es002.s030.t014	.		X
es002.s031.t001	La		X
es002.s031.t002	consola	consola	N
es002.s031.t003	de		X
es002.s031.t004	kalgebra	kalgebra	N
es002.s031.t005	es	ser	V
es002.s031.t006	tan	tan	R
es002.s031.t007	útil	útil	J
es002.s031.t008	como		X
es002.s031.t009	una		X
es002.s031.t010	calculadora	calculadora	N
es002.s031.t011	.		X
es002.s032.t001	Aquí	aquí	R
es002.s032.t002	tiene	tener	V
es002.s032.t003	una		X
es002.s032.t004	lista	lista	N
es002.s032.t005	de		X
es002.s032.t006	las		X
es002.s032.t007	variables	variable	N
es002.s032.t008	declaradas	declarar	V
es002.s032.t009	.		X
es002.s033.t001	Si		X
es002.s033.t002	pulsa	pulsar	V
es002.s033.t003	dos		X
es002.s033.t004	veces	vez	N
es002.s033.t005	sobre		X
es002.s033.t006	una		X
es002.s033.t007	de		X
es002.s033.t008	ellas		X
es002.s033.t009	,		X
es002.s033.t010	le		X
es002.s033.t011	aparecerá	aparecer	V
es002.s033.t012	un		X
es002.s033.t013	diálogo	diálogo	N
es002.s033.t014	con		X
es002.s033.t015	el		X
es002.s033.t016	que		X
es002.s033.t017	podrá	poder	V
es002.s033.t018	cambiar	cambiar	V
es002.s033.t019	su		X
es002.s033.t020	valor	valor	N
es002.s033.t021	(		X
es002.s033.t022	es	ser	V
es002.s033.t023	una		X
es002.s033.t024	forma	forma	N
es002.s033.t025	de		X
es002.s033.t026	engañar	engañar	V
es002.s033.t027	al		X
es002.s033.t028	registro	registro	N
es002.s033.t029	)		X
es002.s033.t030	.		X
es002.s034.t001	Cada vez que		X
es002.s034.t002	introduzca	introducir	V
es002.s034.t003	una		X
es002.s034.t004	expresión	expresión	N
es002.s034.t005	,		X
es002.s034.t006	el		X
es002.s034.t007	valor	valor	N
es002.s034.t008	de		X
es002.s034.t009	la		X
es002.s034.t010	variable	variable	N
es002.s034.t011	«		X
es002.s034.t012	ans	ans	N
es002.s034.t013	»		X
es002.s034.t014	cambiará	cambiar	V
es002.s034.t015	para		X
es002.s034.t016	reproducir	reproducir	V
es002.s034.t017	el		X
es002.s034.t018	último	último	J
es002.s034.t019	resultado	resultado	N
es002.s034.t020	.		X
es002.s035.t001	Ctrl	ctrl	N
es002.s035.t002	N	n	N
es002.s035.t003	Nuevo	nuevo	N
es002.s036.t001	Refresca	refrescar	V
es002.s036.t002	el		X
es002.s036.t003	registro	registro	N
es002.s036.t004	.		X
es002.s037.t001	Ctrl	ctrl	N
es002.s037.t002	L	l	N
es002.s037.t003	Cargar	cargar	V
es002.s037.t004	un		X
es002.s037.t005	guión	guión	N
es002.s038.t001	Ejecuta	ejecutar	V
es002.s038.t002	las		X
es002.s038.t003	instrucciones	instrucción	N
es002.s038.t004	en		X
es002.s038.t005	una		X
es002.s038.t006	archivo	archivo	N
es002.s038.t007	de		X
es002.s038.t008	forma	forma	N
es002.s038.t009	secuencial	secuencial	J
es002.s038.t010	.		X
es002.s039.t001	Es	ser	V
es002.s039.t002	útil	útil	J
es002.s039.t003	si		X
es002.s039.t004	lo		X
es002.s039.t005	que		X
es002.s039.t006	desea	desear	V
es002.s039.t007	es	ser	V
es002.s039.t008	definir	definir	V
es002.s039.t009	una		X
es002.s039.t010	biblioteca	biblioteca	N
es002.s039.t011	o		X
es002.s039.t012	reanudar	reanudar	V
es002.s039.t013	un		X
es002.s039.t014	trabajo	trabajo	N
es002.s039.t015	anterior	anterior	J
es002.s039.t016	.		X
es002.s040.t001	Ctrl	ctrl	N
es002.s040.t002	G	g	N
es002.s040.t003	Guardar	guardar	V
es002.s040.t004	el		X
es002.s040.t005	guión	guión	N
es002.s041.t001	Guarda	guardar	V
es002.s041.t002	las		X
es002.s041.t003	intrucciones	instrucción	N
es002.s041.t004	que		X
es002.s041.t005	ha	haber	V
es002.s041.t006	introducido	introducir	V
es002.s041.t007	desde		X
es002.s041.t008	que		X
es002.s041.t009	comenzó	comenzar	V
es002.s041.t010	la		X
es002.s041.t011	sesión	sesión	N
es002.s041.t012	,		X
es002.s041.t013	con		X
es002.s041.t014	lo		X
es002.s041.t015	que		X
es002.s041.t016	podrá	poder	V
es002.s041.t017	reutilizarlas	reutilizarlas	V
es002.s041.t018	.		X
es002.s042.t001	Genera	generar	V
es002.s042.t002	un		X
es002.s042.t003	archivo	archivo	N
es002.s042.t004	de		X
es002.s042.t005	texto	texto	N
es002.s042.t006	que		X
es002.s042.t007	podrá	poder	V
es002.s042.t008	corregir	corregir	V
es002.s042.t009	usando	usar	V
es002.s042.t010	cualquier		X
es002.s042.t011	editor	editor	N
es002.s042.t012	de		X
es002.s042.t013	texto	texto	N
es002.s042.t014	,		X
es002.s042.t015	por ejemplo	por~ejemplo	R
es002.s042.t016	Kate	kate	N
es002.s042.t017	.		X
es002.s043.t001	Ctrl	ctrl	N
es002.s043.t002	S	s	N
es002.s043.t003	Guardar	guardar	V
es002.s043.t004	el		X
es002.s043.t005	registro	registro	N
es002.s044.t001	Guarda	guardar	V
es002.s044.t002	el		X
es002.s044.t003	registro	registro	N
es002.s044.t004	con		X
es002.s044.t005	todos		X
es002.s044.t006	los		X
es002.s044.t007	resultados	resultado	N
es002.s044.t008	en		X
es002.s044.t009	un		X
es002.s044.t010	archivo	archivo	N
es002.s044.t011	HTML	html	N
es002.s044.t012	que		X
es002.s044.t013	podrá	poder	V
es002.s044.t014	imprimir	imprimir	V
es002.s044.t015	o		X
es002.s044.t016	publicar	publicar	V
es002.s044.t017	.		X
es002.s045.t001	Ctrl	ctrl	N
es002.s045.t002	Q	q	N
es002.s045.t003	Salir	salir	N
es002.s046.t001	Cierra	cerrar	V
es002.s046.t002	el		X
es002.s046.t003	programa	programa	N
es002.s046.t004	.		X
es002.s047.t001	Para		X
es002.s047.t002	añadir	añadir	V
es002.s047.t003	un		X
es002.s047.t004	gráfica	gráfico	J
es002.s047.t005	2D	2d	N
es002.s047.t006	en		X
es002.s047.t007	kalgebra	kalgebra	N
es002.s047.t008	,		X
es002.s047.t009	lo		X
es002.s047.t010	que		X
es002.s047.t011	tiene que	tener~que	V
es002.s047.t012	hacer	hacer	V
es002.s047.t013	es	ser	V
es002.s047.t014	ir	ir	V
es002.s047.t015	a		X
es002.s047.t016	la		X
es002.s047.t017	pestaña	pestaña	N
es002.s047.t018	Gráfica	gráfico	J
es002.s047.t019	2D	2d	N
es002.s047.t020	y		X
es002.s047.t021	aquí	aquí	R
es002.s047.t022	pulsar	pulsar	V
es002.s047.t023	la		X
es002.s047.t024	pestaña	pestaña	N
es002.s047.t025	Añadir	añadir	N
es002.s047.t026	,		X
es002.s047.t027	que		X
es002.s047.t028	le		X
es002.s047.t029	permitirá	permitir	V
es002.s047.t030	añadir	añadir	V
es002.s047.t031	una		X
es002.s047.t032	nueva	nuevo	J
es002.s047.t033	función	función	N
es002.s047.t034	.		X
es002.s048.t001	A		X
es002.s048.t002	continuación	continuación	R
es002.s048.t003	tendrá	tener	V
es002.s048.t004	dirigirse	dirigirse	V
es002.s048.t005	al		X
es002.s048.t006	cuadro	cuadro	N
es002.s048.t007	de		X
es002.s048.t008	texto	texto	N
es002.s048.t009	de		X
es002.s048.t010	entrada	entrada	N
es002.s048.t011	,		X
es002.s048.t012	donde	donde	R
es002.s048.t013	podrá	poder	V
es002.s048.t014	introducir	introducir	V
es002.s048.t015	su		X
es002.s048.t016	función	función	N
es002.s048.t017	.		X
es002.s049.t001	Si		X
es002.s049.t002	quiere	querer	V
es002.s049.t003	usar	usar	V
es002.s049.t004	una		X
es002.s049.t005	función	función	N
es002.s049.t006	f(x)	f(x)	N
es002.s049.t007	típica	típico	J
es002.s049.t008	,		X
es002.s049.t009	no	no	N
es002.s049.t010	es	ser	V
es002.s049.t011	necesario	necesario	J
es002.s049.t012	que		X
es002.s049.t013	la		X
es002.s049.t014	especifique	especificar	V
es002.s049.t015	.		X
es002.s050.t001	Después de		X
es002.s050.t002	haber	haber	V
es002.s050.t003	introducido	introducir	V
es002.s050.t004	la		X
es002.s050.t005	función	función	N
es002.s050.t006	,		X
es002.s050.t007	pulse	pulsar	V
es002.s050.t008	el		X
es002.s050.t009	botón	botón	N
es002.s050.t010	Aceptar	aceptar	V
es002.s050.t011	para		X
es002.s050.t012	dibujar	dibujar	V
es002.s050.t013	la		X
es002.s050.t014	gráfica	gráfica	N
es002.s050.t015	en		X
es002.s050.t016	la		X
es002.s050.t017	ventana	ventana	N
es002.s050.t018	principal	principal	J
es002.s050.t019	.		X
es002.s051.t001	Es	ser	V
es002.s051.t002	posible	posible	J
es002.s051.t003	dibujar	dibujar	V
es002.s051.t004	varias		X
es002.s051.t005	gráficas	gráfica	N
es002.s051.t006	en		X
es002.s051.t007	la		X
es002.s051.t008	misma	mismo	J
es002.s051.t009	vista	vista	N
es002.s051.t010	.		X
es002.s052.t001	Para		X
es002.s052.t002	esto		X
es002.s052.t003	use	usar	V
es002.s052.t004	simplemente	simplemente	R
es002.s052.t005	el		X
es002.s052.t006	botón	botón	N
es002.s052.t007	Añadir	añadir	N
es002.s052.t008	cuando		X
es002.s052.t009	se		X
es002.s052.t010	encuentre	encontrar	V
es002.s052.t011	en		X
es002.s052.t012	el		X
es002.s052.t013	modo	modo	N
es002.s052.t014	Lista	lista	N
es002.s052.t015	.		X
es003.s002.t001	Asistieron	asistir	V
es003.s002.t002	más	más	R
es003.s002.t003	de		X
es003.s002.t004	100		X
es003.s002.t005	participantes	participante	N
es003.s002.t006	en		X
es003.s002.t007	representación	representación	N
es003.s002.t008	de		X
es003.s002.t009	los		X
es003.s002.t010	principales	principal	J
es003.s002.t011	grupos	grupo	N
es003.s002.t012	de		X
es003.s002.t013	interés	interés	N
es003.s002.t014	,		X
es003.s002.t015	los		X
es003.s002.t016	cuales		X
es003.s002.t017	discutieron	discutir	V
es003.s002.t018	cuestiones	cuestión	N
es003.s002.t019	tales		X
es003.s002.t020	como		X
es003.s002.t021	el		X
es003.s002.t022	papel	papel	N
es003.s002.t023	de		X
es003.s002.t024	los		X
es003.s002.t025	principales	principal	J
es003.s002.t026	agentes	agente	N
es003.s002.t027	,		X
es003.s002.t028	entre		X
es003.s002.t029	ellos		X
es003.s002.t030	,		X
es003.s002.t031	las		X
es003.s002.t032	autoridades	autoridad	N
es003.s002.t033	públicas	público	J
es003.s002.t034	,		X
es003.s002.t035	los		X
es003.s002.t036	interlocutores	interlocutor	N
es003.s002.t037	sociales	social	J
es003.s002.t038	y		X
es003.s002.t039	las		X
es003.s002.t040	organizaciones	organización	N
es003.s002.t041	comunitarias	comunitario	J
es003.s002.t042	y		X
es003.s002.t043	de		X
es003.s002.t044	voluntarios	voluntario	N
es003.s002.t045	,		X
es003.s002.t046	además	además	R
es003.s002.t047	de		X
es003.s002.t048	los		X
es003.s002.t049	propios	propio	J
es003.s002.t050	usuarios	usuario	N
es003.s002.t051	.		X
es003.s003.t001	Se		X
es003.s003.t002	llegó	llegar	V
es003.s003.t003	a		X
es003.s003.t004	la		X
es003.s003.t005	conclusión	conclusión	N
es003.s003.t006	de		X
es003.s003.t007	que		X
es003.s003.t008	es	ser	V
es003.s003.t009	necesario	necesario	J
es003.s003.t010	adoptar	adoptar	V
es003.s003.t011	un		X
es003.s003.t012	enfoque	enfoque	N
es003.s003.t013	más	más	R
es003.s003.t014	global	global	J
es003.s003.t015	que		X
es003.s003.t016	tenga en cuenta	tener en cuenta	V
es003.s003.t017	que		X
es003.s003.t018	los		X
es003.s003.t019	usuarios	usuario	N
es003.s003.t020	no	no	N
es003.s003.t021	se		X
es003.s003.t022	sirven	servir	V
es003.s003.t023	de		X
es003.s003.t024	esos		X
es003.s003.t025	servicios	servicio	N
es003.s003.t026	de		X
es003.s003.t027	forma	forma	N
es003.s003.t028	aislada	aislar	V
es003.s003.t029	,		X
es003.s003.t030	sino		X
es003.s003.t031	como		X
es003.s003.t032	parte	parte	N
es003.s003.t033	de		X
es003.s003.t034	su		X
es003.s003.t035	vida	vida	N
es003.s003.t036	cotidiana	cotidiano	J
es003.s003.t037	.		X
es003.s004.t001	Se		X
es003.s004.t002	tomó	tomar	V
es003.s004.t003	nota	nota	N
es003.s004.t004	también	también	R
es003.s004.t005	de		X
es003.s004.t006	la		X
es003.s004.t007	diversidad	diversidad	N
es003.s004.t008	de		X
es003.s004.t009	funciones	función	N
es003.s004.t010	que		X
es003.s004.t011	desempeñan	desempeñar	V
es003.s004.t012	estos		X
es003.s004.t013	servicios	servicio	N
es003.s005.t001	La		X
es003.s005.t002	Fundación	fundación	N
es003.s005.t003	organizó	organizar	V
es003.s005.t004	,		X
es003.s005.t005	junto con		X
es003.s005.t006	la		X
es003.s005.t007	Comisión	comisión	N
es003.s005.t008	Europea	europeo	J
es003.s005.t009	,		X
es003.s005.t010	el		X
es003.s005.t011	Ministerio	ministerio	N
es003.s005.t012	español	español	J
es003.s005.t013	de		X
es003.s005.t014	Asuntos	asunto	N
es003.s005.t015	Sociales	social	J
es003.s005.t016	y		X
es003.s005.t017	la		X
es003.s005.t018	Comunidad	comunidad	N
es003.s005.t019	Autónoma	autónomo	J
es003.s005.t020	de		X
es003.s005.t021	Galicia	galicia	N
es003.s005.t022	,		X
es003.s005.t023	una		X
es003.s005.t024	conferencia	conferencia	N
es003.s005.t025	europea	europeo	J
es003.s005.t026	sobre		X
es003.s005.t027	el		X
es003.s005.t028	tema	tema	N
es003.s005.t029	""""		X
es003.s005.t030	Exclusión	exclusión	N
es003.s005.t031	social	social	J
es003.s005.t032	:		X
es003.s005.t033	Un		X
es003.s005.t034	gran	grande	J
es003.s005.t035	reto	reto	N
es003.s005.t036	para		X
es003.s005.t037	los		X
es003.s005.t038	servicios	servicio	N
es003.s005.t039	públicos	público	J
es003.s005.t040	de		X
es003.s005.t041	protección	protección	N
es003.s005.t042	social	social	J
es003.s005.t043	""""		X
es003.s005.t044	.		X
es003.s006.t001	La		X
es003.s006.t002	Fundación	fundación	N
es003.s006.t003	publicó	publicar	V
es003.s006.t004	recientemente	recientemente	R
es003.s006.t005	en		X
es003.s006.t006	el		X
es003.s006.t007	marco	marco	N
es003.s006.t008	del		X
es003.s006.t009	proyecto	proyecto	N
es003.s006.t010	EPOC	epoc	N
es003.s006.t011	un		X
es003.s006.t012	estudio	estudio	N
es003.s006.t013	comparativo	comparativo	J
es003.s006.t014	en		X
es003.s006.t015	el		X
es003.s006.t016	que		X
es003.s006.t017	se		X
es003.s006.t018	evalúa	evaluar	V
es003.s006.t019	hasta		X
es003.s006.t020	qué		X
es003.s006.t021	punto	punto	N
es003.s006.t022	la		X
es003.s006.t023	participación	participación	N
es003.s006.t024	directa	directo	J
es003.s006.t025	puede	poder	V
es003.s006.t026	humanizar	humanizar	V
es003.s006.t027	el		X
es003.s006.t028	trabajo	trabajo	N
es003.s006.t029	e		X
es003.s006.t030	incrementar	incrementar	V
es003.s006.t031	al mismo tiempo	al~mismo~tiempo	R
es003.s006.t032	la		X
es003.s006.t033	rentabilidad	rentabilidad	N
es003.s006.t034	.		X
es003.s007.t001	El		X
es003.s007.t002	estudio	estudio	N
es003.s007.t003	se		X
es003.s007.t004	basa	basar	V
es003.s007.t005	en		X
es003.s007.t006	195		X
es003.s007.t007	entrevistas	entrevistar	V
es003.s007.t008	personales	personal	J
es003.s007.t009	con		X
es003.s007.t010	altos	alto	J
es003.s007.t011	responsables	responsable	N
es003.s007.t012	de		X
es003.s007.t013	los		X
es003.s007.t014	interlocutores	interlocutor	N
es003.s007.t015	sociales	social	J
es003.s007.t016	,		X
es003.s007.t017	en		X
es003.s007.t018	su		X
es003.s007.t019	calidad	calidad	N
es003.s007.t020	de		X
es003.s007.t021	representantes	representante	N
es003.s007.t022	de		X
es003.s007.t023	importantes	importante	J
es003.s007.t024	organizaciones	organización	N
es003.s007.t025	nacionales	nacional	J
es003.s007.t026	de		X
es003.s007.t027	15		X
es003.s007.t028	países	país	N
es003.s007.t029	europeos	europeo	J
es003.s007.t030	.		X
es003.s008.t001	La		X
es003.s008.t002	industria	industria	N
es003.s008.t003	del		X
es003.s008.t004	metal	metal	N
es003.s008.t005	y		X
es003.s008.t006	el		X
es003.s008.t007	sector	sector	N
es003.s008.t008	bancario	bancario	J
es003.s008.t009	se		X
es003.s008.t010	incluyeron	incluir	V
es003.s008.t011	también	también	R
es003.s008.t012	en		X
es003.s008.t013	atención	atención	N
es003.s008.t014	a		X
es003.s008.t015	su		X
es003.s008.t016	importancia	importancia	N
es003.s008.t017	.		X
es003.s009.t001	Los		X
es003.s009.t002	principales	principal	J
es003.s009.t003	oradores	orador	N
es003.s009.t004	en		X
es003.s009.t005	la		X
es003.s009.t006	conferencia	conferencia	N
es003.s009.t007	sobre		X
es003.s009.t008	exclusión	exclusión	N
es003.s009.t009	socialfueron	socialfueron	J
es003.s009.t010	(		X
es003.s009.t011	de		X
es003.s009.t012	izquierda	izquierda	N
es003.s009.t013	a		X
es003.s009.t014	derecha	derecha	N
es003.s009.t015	)		X
es003.s009.t016	Cristina	cristina	N
es003.s009.t017	Louro	louro	N
es003.s009.t018	,		X
es003.s009.t019	Dirección	dirección	N
es003.s009.t020	General	general	J
es003.s009.t021	de		X
es003.s009.t022	Empleo	empleo	N
es003.s009.t023	,		X
es003.s009.t024	Relaciones	relación	N
es003.s009.t025	Laborales	laboral	J
es003.s009.t026	y		X
es003.s009.t027	Asuntos	asunto	N
es003.s009.t028	Sociales	social	J
es003.s009.t029	de		X
es003.s009.t030	la		X
es003.s009.t031	Comisión	comisión	N
es003.s009.t032	Europea	europeo	J
es003.s009.t033	Fernando	fernando	N
es003.s009.t034	Gomes	gomes	N
es003.s009.t035	,		X
es003.s009.t036	Comité	comité	N
es003.s009.t037	de		X
es003.s009.t038	las		X
es003.s009.t039	Regiones	región	N
es003.s009.t040	Barbara	barbara	N
es003.s009.t041	Weiler	weiler	N
es003.s009.t042	,		X
es003.s009.t043	diputada	diputado	N
es003.s009.t044	al		X
es003.s009.t045	Parlamento	parlamento	N
es003.s009.t046	Europeo	europeo	J
es003.s009.t047	José	josé	N
es003.s009.t048	María	maría	N
es003.s009.t049	Gil-Robles	gil-robles	N
es003.s009.t050	Gil-Delgado	gil-delgado	N
es003.s009.t051	,		X
es003.s009.t052	Vicepresidente	vicepresidente	N
es003.s009.t053	,		X
es003.s009.t054	Parlamento	parlamento	N
es003.s009.t055	Europeo	europeo	J
es003.s009.t056	,		X
es003.s009.t057	John	john	N
es003.s009.t058	Carroll	carroll	N
es003.s009.t059	Comité	comité	N
es003.s009.t060	Económico	económico	J
es003.s009.t061	y		X
es003.s009.t062	Social	social	J
es003.s010.t001	En		X
es003.s010.t002	cada		X
es003.s010.t003	informe	informe	N
es003.s010.t004	nacional	nacional	J
es003.s010.t005	se		X
es003.s010.t006	incluyen	incluir	V
es003.s010.t007	las		X
es003.s010.t008	25		X
es003.s010.t009	o		X
es003.s010.t010	30		X
es003.s010.t011	iniciativas	iniciativa	N
es003.s010.t012	que		X
es003.s010.t013	mejor	bueno	J
es003.s010.t014	reflejan	reflejar	V
es003.s010.t015	prácticas	práctica	N
es003.s010.t016	y		X
es003.s010.t017	políticas	política	N
es003.s010.t018	de		X
es003.s010.t019	mejora	mejora	N
es003.s010.t020	de		X
es003.s010.t021	la		X
es003.s010.t022	contratación	contratación	N
es003.s010.t023	,		X
es003.s010.t024	la		X
es003.s010.t025	formación	formación	N
es003.s010.t026	y		X
es003.s010.t027	el		X
es003.s010.t028	desarrollo	desarrollo	N
es003.s010.t029	profesional	profesional	J
es003.s010.t030	de		X
es003.s010.t031	los		X
es003.s010.t032	trabajadores	trabajador	N
es003.s010.t033	mayores	grande	J
es003.s010.t034	en		X
es003.s010.t035	el		X
es003.s010.t036	lugar	lugar	N
es003.s010.t037	de		X
es003.s010.t038	trabajo	trabajo	N
es003.s010.t039	y		X
es003.s010.t040	a nivel de		X
es003.s010.t041	la		X
es003.s010.t042	comunidad	comunidad	N
es003.s010.t043	.		X
es003.s011.t001	Se		X
es003.s011.t002	seleccionaron	seleccionar	V
es003.s011.t003	dos		X
es003.s011.t004	o		X
es003.s011.t005	tres		X
es003.s011.t006	iniciativas	iniciativa	N
es003.s011.t007	por		X
es003.s011.t008	cada		X
es003.s011.t009	país	país	N
es003.s011.t010	,		X
es003.s011.t011	para		X
es003.s011.t012	que		X
es003.s011.t013	fueran	ser	V
es003.s011.t014	objeto	objeto	N
es003.s011.t015	de		X
es003.s011.t016	un		X
es003.s011.t017	estudio	estudio	N
es003.s011.t018	de		X
es003.s011.t019	caso	caso	N
es003.s011.t020	detallado	detallar	V
es003.s011.t021	.		X
es003.s012.t001	En		X
es003.s012.t002	estos		X
es003.s012.t003	estudios	estudio	N
es003.s012.t004	de		X
es003.s012.t005	caso	caso	N
es003.s012.t006	se		X
es003.s012.t007	han	haber	V
es003.s012.t008	analizado	analizar	V
es003.s012.t009	el		X
es003.s012.t010	contexto	contexto	N
es003.s012.t011	de		X
es003.s012.t012	esas		X
es003.s012.t013	iniciativas	iniciativa	N
es003.s012.t014	y		X
es003.s012.t015	sus		X
es003.s012.t016	repercusiones	repercusión	N
es003.s012.t017	en		X
es003.s012.t018	las		X
es003.s012.t019	pautas	pauta	N
es003.s012.t020	de		X
es003.s012.t021	empleo	empleo	N
es003.s012.t022	y		X
es003.s012.t023	en		X
es003.s012.t024	las		X
es003.s012.t025	organizaciones	organización	N
es003.s012.t026	,		X
es003.s012.t027	y		X
es003.s012.t028	se		X
es003.s012.t029	han	haber	V
es003.s012.t030	evaluado	evaluar	V
es003.s012.t031	las		X
es003.s012.t032	ventajas	ventaja	N
es003.s012.t033	y		X
es003.s012.t034	problemas	problema	N
es003.s012.t035	derivados	derivar	V
es003.s012.t036	de		X
es003.s012.t037	las		X
es003.s012.t038	mismas	mismo	J
es003.s012.t039	.		X
es003.s013.t001	Se		X
es003.s013.t002	han	haber	V
es003.s013.t003	realizado	realizar	V
es003.s013.t004	además	además	R
es003.s013.t005	visitas	visita	N
es003.s013.t006	y		X
es003.s013.t007	entrevistas	entrevista	N
es003.s013.t008	a		X
es003.s013.t009	miembros	miembro	N
es003.s013.t010	clave	clave	J
es003.s013.t011	del		X
es003.s013.t012	personal	personal	N
es003.s013.t013	.		X
es003.s014.t001	Estos		X
es003.s014.t002	estudios	estudio	N
es003.s014.t003	nacionales	nacional	J
es003.s014.t004	constituirán	constituir	V
es003.s014.t005	la		X
es003.s014.t006	liase	liar	V
es003.s014.t007	de		X
es003.s014.t008	un		X
es003.s014.t009	informe	informe	N
es003.s014.t010	europeo	europeo	J
es003.s014.t011	en		X
es003.s014.t012	el		X
es003.s014.t013	que		X
es003.s014.t014	se		X
es003.s014.t015	resumirán	resumir	V
es003.s014.t016	las		X
es003.s014.t017	prácticas	práctico	J
es003.s014.t018	generales	general	J
es003.s014.t019	.		X
es003.s015.t001	El		X
es003.s015.t002	informe	informe	N
es003.s015.t003	y		X
es003.s015.t004	un		X
es003.s015.t005	repertorio	repertorio	N
es003.s015.t006	de		X
es003.s015.t007	iniciativas	iniciativa	N
es003.s015.t008	se		X
es003.s015.t009	publicarán	publicar	V
es003.s015.t010	en		X
es003.s015.t011	1996		X
es003.s015.t012	,		X
es003.s015.t013	y		X
es003.s015.t014	servirán	servir	V
es003.s015.t015	de		X
es003.s015.t016	telón	telón	N
es003.s015.t017	de		X
es003.s015.t018	fondo	fondo	N
es003.s015.t019	a		X
es003.s015.t020	una		X
es003.s015.t021	conferencia	conferencia	N
es003.s015.t022	que		X
es003.s015.t023	se		X
es003.s015.t024	celebrará	celebrar	V
es003.s015.t025	el		X
es003.s015.t026	próximo	próximo	J
es003.s015.t027	otoño	otoño	N
es003.s015.t028	.		X
es003.s016.t001	La		X
es003.s016.t002	Fundación	fundación	N
es003.s016.t003	se		X
es003.s016.t004	propone	proponer	V
es003.s016.t005	documentar	documentar	V
es003.s016.t006	las		X
es003.s016.t007	características	característica	N
es003.s016.t008	de		X
es003.s016.t009	los		X
es003.s016.t010	obstáculos	obstáculo	N
es003.s016.t011	relacionados	relacionar	V
es003.s016.t012	con		X
es003.s016.t013	la		X
es003.s016.t014	edad	edad	N
es003.s016.t015	en		X
es003.s016.t016	materia	meteria	N
es003.s016.t017	de		X
es003.s016.t018	contratación	contratación	N
es003.s016.t019	y		X
es003.s016.t020	formación	formación	N
es003.s016.t021	,		X
es003.s016.t022	y		X
es003.s016.t023	analizar	analizar	V
es003.s016.t024	sus		X
es003.s016.t025	causas	causa	N
es003.s016.t026	.		X
es003.s017.t001	Está	estar	V
es003.s017.t002	examinando	examinar	V
es003.s017.t003	asimismo	asimismo	R
es003.s017.t004	los		X
es003.s017.t005	puntos	punto	N
es003.s017.t006	de		X
es003.s017.t007	vista	vista	N
es003.s017.t008	de		X
es003.s017.t009	los		X
es003.s017.t010	interlocutores	interlocutor	N
es003.s017.t011	sociales	social	J
es003.s017.t012	,		X
es003.s017.t013	prestando	prestar	V
es003.s017.t014	especial	especial	J
es003.s017.t015	atención	atención	N
es003.s017.t016	a		X
es003.s017.t017	las		X
es003.s017.t018	propuestas	propuesta	N
es003.s017.t019	para		X
es003.s017.t020	eliminar	eliminar	V
es003.s017.t021	dichos		X
es003.s017.t022	obstáculos	obstáculo	N
es003.s017.t023	.		X
es003.s018.t001	En		X
es003.s018.t002	tercer		X
es003.s018.t003	lugar	lugar	N
es003.s018.t004	,		X
es003.s018.t005	el		X
es003.s018.t006	proyecto	proyecto	N
es003.s018.t007	documenta	documentar	V
es003.s018.t008	y		X
es003.s018.t009	evalúa	evaluar	V
es003.s018.t010	las		X
es003.s018.t011	iniciativas	iniciativa	N
es003.s018.t012	de		X
es003.s018.t013	los		X
es003.s018.t014	sectores	sector	N
es003.s018.t015	público	público	J
es003.s018.t016	y		X
es003.s018.t017	privado	privado	J
es003.s018.t018	para		X
es003.s018.t019	combatir	combatir	V
es003.s018.t020	estas		X
es003.s018.t021	limitaciones	limitación	N
es003.s018.t022	,		X
es003.s018.t023	especialmente	especialmente	R
es003.s018.t024	en relación con		X
es003.s018.t025	los		X
es003.s018.t026	trabajadores	trabajador	N
es003.s018.t027	mayores	grande	J
es003.s018.t028	.		X
es003.s019.t001	El		X
es003.s019.t002	proyecto	proyecto	N
es003.s019.t003	,		X
es003.s019.t004	que		X
es003.s019.t005	busca	buscar	V
es003.s019.t006	alternativas	alternativa	N
es003.s019.t007	a		X
es003.s019.t008	la		X
es003.s019.t009	jubilación	jubilación	N
es003.s019.t010	anticipada	anticipado	J
es003.s019.t011	y		X
es003.s019.t012	al		X
es003.s019.t013	despido	despido	N
es003.s019.t014	,		X
es003.s019.t015	se		X
es003.s019.t016	ocupa	ocupar	V
es003.s019.t017	ante		X
es003.s019.t018	todo		X
es003.s019.t019	de		X
es003.s019.t020	la		X
es003.s019.t021	retención	retención	N
es003.s019.t022	,		X
es003.s019.t023	la		X
es003.s019.t024	reintegración	reintegración	N
es003.s019.t025	y		X
es003.s019.t026	la		X
es003.s019.t027	reconversión	reconversión	N
es003.s019.t028	profesional	profesional	J
es003.s019.t029	de		X
es003.s019.t030	los		X
es003.s019.t031	trabajadores	trabajador	N
es003.s019.t032	mayores	grande	J
es003.s019.t033	.		X
es003.s020.t001	Estudia	estudiar	V
es003.s020.t002	asimismo	asimismo	R
es003.s020.t003	liasta	liasta	N
es003.s020.t004	qué		X
es003.s020.t005	punto	punto	N
es003.s020.t006	influyen	influir	V
es003.s020.t007	el		X
es003.s020.t008	sexo	sexo	N
es003.s020.t009	y		X
es003.s020.t010	la		X
es003.s020.t011	raza	raza	N
es003.s020.t012	de		X
es003.s020.t013	los		X
es003.s020.t014	trabajadores	trabajador	N
es003.s020.t015	en		X
es003.s020.t016	la		X
es003.s020.t017	discriminación	discriminación	N
es003.s020.t018	por		X
es003.s020.t019	razón	razón	N
es003.s020.t020	de		X
es003.s020.t021	la		X
es003.s020.t022	edad	edad	N
es003.s020.t023	.		X
es003.s021.t001	El		X
es003.s021.t002	proyecto	proyecto	N
es003.s021.t003	tiene	tener	V
es003.s021.t004	en		X
es003.s021.t005	cuenta	cuenta	N
es003.s021.t006	,		X
es003.s021.t007	por		X
es003.s021.t008	otra		X
es003.s021.t009	paite	paite	N
es003.s021.t010	,		X
es003.s021.t011	las		X
es003.s021.t012	iniciativas	iniciativa	N
es003.s021.t013	para		X
es003.s021.t014	luchar	luchar	V
es003.s021.t015	contra		X
es003.s021.t016	esta		X
es003.s021.t017	clase	clase	N
es003.s021.t018	de		X
es003.s021.t019	discriminación	discriminación	N
es003.s021.t020	en		X
es003.s021.t021	las		X
es003.s021.t022	zonas	zona	N
es003.s021.t023	rurales	rural	J
es003.s021.t024	y		X
es003.s021.t025	en		X
es003.s021.t026	las		X
es003.s021.t027	pequeñas	pequeño	J
es003.s021.t028	y		X
es003.s021.t029	medianas	mediano	J
es003.s021.t030	empresas	empresa	N
es003.s021.t031	.		X
es003.s022.t001	Siete		X
es003.s022.t002	Estados	estado	N
es003.s022.t003	miembros	miembro	N
es003.s022.t004	se		X
es003.s022.t005	incluyen	incluir	V
es003.s022.t006	en		X
es003.s022.t007	el		X
es003.s022.t008	proyecto	proyecto	N
es003.s022.t009	:		X
es003.s022.t010	Alemania	alemania	N
es003.s022.t011	,		X
es003.s022.t012	Bélgica	bélgica	N
es003.s022.t013	,		X
es003.s022.t014	Francia	francia	N
es003.s022.t015	,		X
es003.s022.t016	Grecia	grecia	N
es003.s022.t017	,		X
es003.s022.t018	Italia	italia	N
es003.s022.t019	,		X
es003.s022.t020	Países Bajos	países~bajos	N
es003.s022.t021	y		X
es003.s022.t022	Reino Unido	reino~unido	N
es003.s022.t023	.		X
es004.s001.t001	Resumen	resumir	V
es004.s001.t002	del		X
es004.s001.t003	EPAR	epar	N
es004.s001.t004	para		X
es004.s001.t005	el		X
es004.s001.t006	público	público	N
es004.s001.t007	general	general	J
es004.s002.t001	En		X
es004.s002.t002	el		X
es004.s002.t003	presente	presente	J
es004.s002.t004	documento	documento	N
es004.s002.t005	se		X
es004.s002.t006	resume	resumir	V
es004.s002.t007	el		X
es004.s002.t008	Informe	informe	N
es004.s002.t009	Público	público	J
es004.s002.t010	Europeo	europeo	J
es004.s002.t011	de		X
es004.s002.t012	Evaluación	evaluación	N
es004.s002.t013	,		X
es004.s002.t014	y		X
es004.s002.t015	se		X
es004.s002.t016	explica	explicar	V
es004.s002.t017	cómo	cómo	R
es004.s002.t018	la		X
es004.s002.t019	evaluación	evaluación	N
es004.s002.t020	del		X
es004.s002.t021	Comité	comité	N
es004.s002.t022	de		X
es004.s002.t023	Medicamentos	medicamento	N
es004.s002.t024	de		X
es004.s002.t025	Uso	uso	N
es004.s002.t026	Veterinario	veterinario	N
es004.s002.t027	(		X
es004.s002.t028	CVMP	cvmp	N
es004.s002.t029	)		X
es004.s002.t030	,		X
es004.s002.t031	efectuada	efectuar	V
es004.s002.t032	a partir de		X
es004.s002.t033	los		X
es004.s002.t034	estudios	estudio	N
es004.s002.t035	existentes	existente	J
es004.s002.t036	,		X
es004.s002.t037	ha	haber	V
es004.s002.t038	llevado	llevar	V
es004.s002.t039	a		X
es004.s002.t040	las		X
es004.s002.t041	recomendaciones	recomendación	N
es004.s002.t042	sobre		X
es004.s002.t043	las		X
es004.s002.t044	condiciones	condición	N
es004.s002.t045	de		X
es004.s002.t046	uso	uso	N
es004.s002.t047	del		X
es004.s002.t048	medicamento	medicamento	N
es004.s002.t049	.		X
es004.s003.t001	¿Qué	¿qué	R
es004.s003.t002	es	ser	V
es004.s003.t003	Cerenia	cerenia	N
es004.s003.t004	?		X
es004.s004.t001	Cerenia	cerenia	N
es004.s004.t002	contiene	contener	V
es004.s004.t003	el		X
es004.s004.t004	principio	principio	N
es004.s004.t005	activo	activo	J
es004.s004.t006	maropitant	maropitant	N
es004.s004.t007	y		X
es004.s004.t008	se		X
es004.s004.t009	presenta	presentar	V
es004.s004.t010	en		X
es004.s004.t011	forma	forma	N
es004.s004.t012	de		X
es004.s004.t013	comprimidos	comprimir	V
es004.s004.t014	o		X
es004.s004.t015	de		X
es004.s004.t016	solución	solución	N
es004.s004.t017	inyectables	inyectables	J
es004.s004.t018	.		X
es004.s005.t001	Los		X
es004.s005.t002	comprimidos	comprimir	V
es004.s005.t003	son	ser	V
es004.s005.t004	de		X
es004.s005.t005	color	color	N
es004.s005.t006	naranja	naranja	N
es004.s005.t007	claro	claro	J
es004.s005.t008	y		X
es004.s005.t009	tienen	tener	V
es004.s005.t010	una		X
es004.s005.t011	ranura	ranura	N
es004.s005.t012	en		X
es004.s005.t013	ambas		X
es004.s005.t014	caras	cara	N
es004.s005.t015	,		X
es004.s005.t016	lo		X
es004.s005.t017	que		X
es004.s005.t018	permite	permitir	V
es004.s005.t019	dividirlos	dividir	V
es004.s005.t020	por		X
es004.s005.t021	la		X
es004.s005.t022	mitad	mitad	N
es004.s005.t023	.		X
es004.s006.t001	Cada		X
es004.s006.t002	comprimido	comprimido	N
es004.s006.t003	va	ir	V
es004.s006.t004	marcado	marcar	V
es004.s006.t005	con		X
es004.s006.t006	el		X
es004.s006.t007	logo	logo	N
es004.s006.t008	Pfizer	pfizer	N
es004.s006.t009	en		X
es004.s006.t010	una		X
es004.s006.t011	cara	cara	N
es004.s006.t012	y		X
es004.s006.t013	las		X
es004.s006.t014	letras	letra	N
es004.s006.t015	MPT	mpt	N
es004.s006.t016	y		X
es004.s006.t017	la		X
es004.s006.t018	cantidad	cantidad	N
es004.s006.t019	de		X
es004.s006.t020	maropitant	maropitant	N
es004.s006.t021	en		X
es004.s006.t022	la		X
es004.s006.t023	otra		X
es004.s006.t024	.		X
es004.s007.t001	¿Para	¿para	V
es004.s007.t002	qué		X
es004.s007.t003	se		X
es004.s007.t004	utiliza	utilizar	V
es004.s007.t005	Cerenia	cerenia	N
es004.s007.t006	?		X
es004.s008.t001	Cerenia	cerenia	N
es004.s008.t002	es	ser	V
es004.s008.t003	un		X
es004.s008.t004	antiemético	antiemético	N
es004.s008.t005	(		X
es004.s008.t006	ataja	atajar	V
es004.s008.t007	los		X
es004.s008.t008	vómitos	vómito	N
es004.s008.t009	)		X
es004.s008.t010	.		X
es004.s009.t001	Se		X
es004.s009.t002	utiliza	utilizar	V
es004.s009.t003	en		X
es004.s009.t004	perros	perro	N
es004.s009.t005	para		X
es004.s009.t006	la		X
es004.s009.t007	prevención	prevención	N
es004.s009.t008	de		X
es004.s009.t009	los		X
es004.s009.t010	vómitos	vómito	N
es004.s009.t011	,		X
es004.s009.t012	por ejemplo	por~ejemplo	R
es004.s009.t013	los		X
es004.s009.t014	causados	causar	V
es004.s009.t015	por		X
es004.s009.t016	la		X
es004.s009.t017	quimioterapia	quimioterapia	N
es004.s009.t018	(		X
es004.s009.t019	fármacos	fármaco	N
es004.s009.t020	utilizados	utilizar	V
es004.s009.t021	para		X
es004.s009.t022	el		X
es004.s009.t023	tratamiento	tratamiento	N
es004.s009.t024	del		X
es004.s009.t025	cáncer	cáncer	N
es004.s009.t026	,		X
es004.s009.t027	algunos		X
es004.s009.t028	de		X
es004.s009.t029	los		X
es004.s009.t030	cuales		X
es004.s009.t031	producen	producir	V
es004.s009.t032	vómitos	vómito	N
es004.s009.t033	)		X
es004.s009.t034	.		X
es004.s010.t001	Combinado	combinar	V
es004.s010.t002	con		X
es004.s010.t003	otras		X
es004.s010.t004	medidas	medida	N
es004.s010.t005	complementarias	complementario	J
es004.s010.t006	,		X
es004.s010.t007	como		X
es004.s010.t008	otros		X
es004.s010.t009	tratamientos	tratamiento	N
es004.s010.t010	veterinarios	veterinario	N
es004.s010.t011	o		X
es004.s010.t012	una		X
es004.s010.t013	dieta	dieta	N
es004.s010.t014	especial	especial	J
es004.s010.t015	,		X
es004.s010.t016	Cerenia	cerenia	N
es004.s010.t017	se		X
es004.s010.t018	utiliza	utilizar	V
es004.s010.t019	también	también	R
es004.s010.t020	como		X
es004.s010.t021	tratamiento	tratamiento	N
es004.s010.t022	del		X
es004.s010.t023	vómito	vómito	N
es004.s010.t024	(		X
es004.s010.t025	como		X
es004.s010.t026	inyección	inyección	N
es004.s010.t027	o		X
es004.s010.t028	como		X
es004.s010.t029	inyección	inyección	N
es004.s010.t030	seguida	seguir	V
es004.s010.t031	de		X
es004.s010.t032	comprimidos	comprimir	V
es004.s010.t033	)		X
es004.s010.t034	.		X
es004.s011.t001	A		X
es004.s011.t002	estos		X
es004.s011.t003	efectos	efecto	N
es004.s011.t004	,		X
es004.s011.t005	Cerenia	cerenia	N
es004.s011.t006	se		X
es004.s011.t007	puede	poder	V
es004.s011.t008	administrar	administrar	V
es004.s011.t009	durante		X
es004.s011.t010	un		X
es004.s011.t011	período	período	N
es004.s011.t012	de		X
es004.s011.t013	hasta		X
es004.s011.t014	cinco		X
es004.s011.t015	días	día	N
es004.s011.t016	.		X
es004.s012.t001	¿Cómo	¿cómo	N
es004.s012.t002	actúa	actuar	V
es004.s012.t003	Cerenia	cerenia	N
es004.s012.t004	?		X
es004.s013.t001	Cerenia	cerenia	N
es004.s013.t002	bloquea	bloquear	V
es004.s013.t003	los		X
es004.s013.t004	receptores	receptor	N
es004.s013.t005	de		X
es004.s013.t006	neurocinina	neurocinina	N
es004.s013.t007	1		X
es004.s013.t008	(		X
es004.s013.t009	NK1	nk1	N
es004.s013.t010	)		X
es004.s013.t011	en		X
es004.s013.t012	el		X
es004.s013.t013	sistema	sistema	N
es004.s013.t014	nervioso	nervioso	J
es004.s013.t015	central	central	J
es004.s013.t016	.		X
es004.s014.t001	¿Qué	¿qué	V
es004.s014.t002	tipo	tipo	N
es004.s014.t003	de		X
es004.s014.t004	estudios	estudio	N
es004.s014.t005	se		X
es004.s014.t006	han	haber	V
es004.s014.t007	realizado	realizar	V
es004.s014.t008	sobre		X
es004.s014.t009	Cerenia	cerenia	N
es004.s014.t010	?		X
es004.s015.t001	Se		X
es004.s015.t002	han	haber	V
es004.s015.t003	realizado	realizar	V
es004.s015.t004	una		X
es004.s015.t005	gran	grande	J
es004.s015.t006	cantidad	cantidad	N
es004.s015.t007	de		X
es004.s015.t008	estudios	estudio	N
es004.s015.t009	con		X
es004.s015.t010	Cerenia	cerenia	N
es004.s015.t011	en		X
es004.s015.t012	perros	perro	N
es004.s015.t013	de		X
es004.s015.t014	laboratorio	laboratorio	N
es004.s015.t015	y		X
es004.s015.t016	en		X
es004.s015.t017	perros	perro	N
es004.s015.t018	pacientes	paciente	J
es004.s015.t019	de		X
es004.s015.t020	clínicas	clínico	J
es004.s015.t021	veterinarias	veterinario	N
es004.s015.t022	de		X
es004.s015.t023	varios		X
es004.s015.t024	países	país	N
es004.s015.t025	europeos	europeo	J
es004.s015.t026	y		X
es004.s015.t027	de		X
es004.s015.t028	EE.UU.	ee.uu.	N
es004.s016.t001	¿Qué	¿qué	N
es004.s016.t002	beneficios	beneficio	N
es004.s016.t003	ha	haber	V
es004.s016.t004	demostrado	demostrar	V
es004.s016.t005	Cerenia	cerenia	N
es004.s016.t006	durante		X
es004.s016.t007	dichos		X
es004.s016.t008	estudios	estudio	N
es004.s016.t009	?		X
es004.s017.t001	Los		X
es004.s017.t002	resultados	resultado	N
es004.s017.t003	de		X
es004.s017.t004	los		X
es004.s017.t005	estudios	estudio	N
es004.s017.t006	demostraron	demostrar	V
es004.s017.t007	que		X
es004.s017.t008	Cerenia	cerenia	N
es004.s017.t009	fue	ser	V
es004.s017.t010	más	más	R
es004.s017.t011	eficaz	eficaz	J
es004.s017.t012	que		X
es004.s017.t013	el		X
es004.s017.t014	placebo	placebo	N
es004.s017.t015	:		X
es004.s017.t016	se		X
es004.s017.t017	observaron	observar	V
es004.s017.t018	menos	menos	R
es004.s017.t019	vómitos	vómito	N
es004.s017.t020	en		X
es004.s017.t021	los		X
es004.s017.t022	perros	perro	N
es004.s017.t023	que		X
es004.s017.t024	recibieron	recibir	V
es004.s017.t025	el		X
es004.s017.t026	medicamento	medicamento	N
es004.s017.t027	que		X
es004.s017.t028	en		X
es004.s017.t029	los		X
es004.s017.t030	perros	perro	N
es004.s017.t031	que		X
es004.s017.t032	recibieron	recibir	V
es004.s017.t033	placebo	placebo	N
es004.s017.t034	,		X
es004.s017.t035	bien		X
es004.s017.t036	como		X
es004.s017.t037	tratamiento	tratamiento	N
es004.s017.t038	,		X
es004.s017.t039	bien		X
es004.s017.t040	como		X
es004.s017.t041	prevención	prevención	N
es004.s017.t042	del		X
es004.s017.t043	vómito	vómito	N
es004.s017.t044	.		X
es004.s018.t001	El		X
es004.s018.t002	tratamiento	tratamiento	N
es004.s018.t003	de		X
es004.s018.t004	un		X
es004.s018.t005	perro	perro	N
es004.s018.t006	con		X
es004.s018.t007	vómitos	vómito	N
es004.s018.t008	debe	deber	V
es004.s018.t009	iniciarse	iniciarse	V
es004.s018.t010	en		X
es004.s018.t011	forma	forma	N
es004.s018.t012	inyectable	inyectable	J
es004.s018.t013	puesto que		X
es004.s018.t014	los		X
es004.s018.t015	animales	animal	N
es004.s018.t016	con		X
es004.s018.t017	vómitos	vómito	N
es004.s018.t018	podrían	poder	V
es004.s018.t019	no	no	N
es004.s018.t020	retener	retener	V
es004.s018.t021	el		X
es004.s018.t022	comprimido	comprimir	V
es004.s018.t023	(		X
es004.s018.t024	podrían	poder	V
es004.s018.t025	vomitar	vomitar	V
es004.s018.t026	el		X
es004.s018.t027	comprimido	comprimir	V
es004.s018.t028	intacto	intacto	J
es004.s018.t029	)		X
es004.s018.t030	.		X
es004.s019.t001	Para		X
es004.s019.t002	la		X
es004.s019.t003	continuación	continuación	N
es004.s019.t004	del		X
es004.s019.t005	tratamiento	tratamiento	N
es004.s019.t006	,		X
es004.s019.t007	el		X
es004.s019.t008	propietario	propietario	N
es004.s019.t009	puede	poder	V
es004.s019.t010	administrar	administrar	V
es004.s019.t011	el		X
es004.s019.t012	medicamento	medicamento	N
es004.s019.t013	al		X
es004.s019.t014	animal	animal	N
es004.s019.t015	en		X
es004.s019.t016	forma	forma	N
es004.s019.t017	de		X
es004.s019.t018	comprimidos	comprimir	V
es004.s019.t019	.		X
es004.s020.t001	El		X
es004.s020.t002	tratamiento	tratamiento	N
es004.s020.t003	del		X
es004.s020.t004	vómito	vómito	N
es004.s020.t005	debe	deber	V
es004.s020.t006	realizarse	realizar	V
es004.s020.t007	siempre	siempre	R
es004.s020.t008	en		X
es004.s020.t009	asociación	asociación	N
es004.s020.t010	con		X
es004.s020.t011	otras		X
es004.s020.t012	medidas	medida	N
es004.s020.t013	de		X
es004.s020.t014	apoyo	apoyo	N
es004.s020.t015	u		X
es004.s020.t016	otros		X
es004.s020.t017	tratamientos	tratamiento	N
es004.s020.t018	veterinarios	veterinario	N
es004.s020.t019	para		X
es004.s020.t020	combatir	combatir	V
es004.s020.t021	también	también	R
es004.s020.t022	la		X
es004.s020.t023	causa	causa	N
es004.s020.t024	subyacente	subyacente	J
es004.s020.t025	del		X
es004.s020.t026	vómito	vómito	N
es004.s020.t027	.		X
es004.s021.t001	¿Cuáles	¿cuáles	J
es004.s021.t002	son	ser	V
es004.s021.t003	los		X
es004.s021.t004	efectos	efecto	N
es004.s021.t005	secundarios	secundario	J
es004.s021.t006	de		X
es004.s021.t007	Cerenia	cerenia	N
es004.s021.t008	?		X
es004.s022.t001	En general	en~general	R
es004.s022.t002	,		X
es004.s022.t003	Cerenia	cerenia	N
es004.s022.t004	fue	ser	V
es004.s022.t005	bien	bien	R
es004.s022.t006	tolerado	tolerar	V
es004.s022.t007	cuando		X
es004.s022.t008	se		X
es004.s022.t009	administró	administrar	V
es004.s022.t010	diariamente	diariamente	R
es004.s022.t011	a		X
es004.s022.t012	dosis	dosis	N
es004.s022.t013	de		X
es004.s022.t014	hasta		X
es004.s022.t015	5		X
es004.s022.t016	veces	vez	N
es004.s022.t017	la		X
es004.s022.t018	dosis	dosis	N
es004.s022.t019	recomendada	recomendar	V
es004.s022.t020	durante		X
es004.s022.t021	un		X
es004.s022.t022	período	período	N
es004.s022.t023	de		X
es004.s022.t024	tiempo	tiempo	N
es004.s022.t025	prolongado	prolongar	V
es004.s022.t026	(		X
es004.s022.t027	hasta		X
es004.s022.t028	3		X
es004.s022.t029	veces	vez	N
es004.s022.t030	la		X
es004.s022.t031	duración	duración	N
es004.s022.t032	máxima	grande	J
es004.s022.t033	recomendada	recomendar	V
es004.s022.t034	del		X
es004.s022.t035	tratamiento	tratamiento	N
es004.s022.t036	)		X
es004.s022.t037	.		X
es004.s023.t001	¿Qué	¿qué	V
es004.s023.t002	precauciones	precaución	N
es004.s023.t003	debe	deber	V
es004.s023.t004	adoptar	adoptar	V
es004.s023.t005	la		X
es004.s023.t006	persona	persona	N
es004.s023.t007	que		X
es004.s023.t008	administre	administrar	V
es004.s023.t009	el		X
es004.s023.t010	medicamento	medicamento	N
es004.s023.t011	o		X
es004.s023.t012	esté	estar	V
es004.s023.t013	en		X
es004.s023.t014	contacto	contacto	N
es004.s023.t015	con		X
es004.s023.t016	el		X
es004.s023.t017	animal	animal	N
es004.s023.t018	?		X
es004.s024.t001	Cerenia	cerenia	N
es004.s024.t002	no	no	N
es004.s024.t003	presenta	presentar	V
es004.s024.t004	ningún		X
es004.s024.t005	riesgo	riesgo	N
es004.s024.t006	especial	especial	J
es004.s024.t007	para		X
es004.s024.t008	el		X
es004.s024.t009	ser	ser	N
es004.s024.t010	humano	humano	J
es004.s024.t011	.		X
